Details of Disease

General Information of Disease (ID: DISIJDBA)

• Disease Name: Anxiety
• Synonyms: harm avoidance; anxiety-related personality traits; anxiety
• Disease Hierarchy:
  DISBI2BT: Anxiety disorder
  DISD715V: Hereditary neurological disease
  DISIJDBA: Anxiety
• Disease Identifiers:
  MONDO ID: MONDO_0011918
  MESH ID: D001007
  UMLS CUI: C0003467
  OMIM ID: 607834
  MedGen ID: 1613
  HPO ID: HP:0000739
  SNOMED CT ID: 48694002

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 16 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Alprazolam	DMC7XDN	Approved	Small molecular drug	[1]
Chlordiazepoxide	DMTN5XI	Approved	Small molecular drug	[2]
Citalopram	DM2G9AE	Approved	Small molecular drug	[3]
Clorazepate	DMC3JST	Approved	Small molecular drug	[4]
Diazepam	DM08E9O	Approved	Small molecular drug	[5]
Doxepin	DMPI98T	Approved	Small molecular drug	[6]
Ketamine	DMT5HA4	Approved	Small molecular drug	[7]
Lorazepam	DM84ZXF	Approved	Small molecular drug	[8]
Meprobamate	DMHM93Y	Approved	Small molecular drug	[9]
Methamphetamine	DMPM4SK	Approved	Small molecular drug	[10]
Methylphenobarbital	DMDSWAG	Approved	Small molecular drug	[11]
Midazolam	DMXOELT	Approved	Small molecular drug	[12]
Oxazepam	DMXNZM4	Approved	Small molecular drug	[13]
Oxprenolol	DM51OQW	Approved	Small molecular drug	[14]
Prazepam	DMEWC7N	Approved	Small molecular drug	[15]
Trifluoperazine	DMKBYWI	Approved	Small molecular drug	[16]

Molecular Interaction Atlas (MIA) of This Disease

This Disease Is Related to 163 DTT Molecule(s)

Gene Name	DTT ID	Evidence Level	Mode of Inheritance	REF
ADRA2B	TTWM4TY	Limited	Altered Expression	[17]
APLN	TT87D3J	Limited	Altered Expression	[18]
CACNA1C	TTZIFHC	Limited	Genetic Variation	[19]
CAMKK2	TTV298Y	Limited	Biomarker	[20]
CCKBR	TTVFO0U	Limited	Altered Expression	[21]
CFI	TT6ATLX	Limited	Biomarker	[22]
CFP	TTLA0VS	Limited	Genetic Variation	[23]
CHRNA2	TTF4E0J	Limited	Biomarker	[24]
CHRNA4	TT4H1MQ	Limited	Biomarker	[25]
CNP	TT71P0H	Limited	Altered Expression	[26]
CNR2	TTMSFAW	Limited	Biomarker	[27]
CPM	TTVOH2M	Limited	Biomarker	[28]
CRHBP	TT3PKZE	Limited	Biomarker	[29]
DYRK1A	TTSBVFO	Limited	Biomarker	[30]
FDPS	TTIKWV4	Limited	Biomarker	[31]
FES	TTLBY21	Limited	Biomarker	[31]
FKBP4	TTHY0FT	Limited	Genetic Variation	[32]
FST	TTDNM9W	Limited	Biomarker	[33]
GABRA2	TTBMV1G	Limited	Biomarker	[34]
GAL	TTXZAJ5	Limited	Biomarker	[35]
GALR2	TTBPW3J	Limited	Biomarker	[36]
GPER1	TTDSB34	Limited	Biomarker	[37]
GPNMB	TT7315J	Limited	Genetic Variation	[38]
GPR55	TTNET8J	Limited	Biomarker	[39]
GRIA1	TTVPQTF	Limited	Biomarker	[40]
GRIA2	TTWM461	Limited	Altered Expression	[41]
GRM5	TTHS256	Limited	Biomarker	[42]
HCRTR1	TT60Q8D	Limited	Genetic Variation	[43]
HSD11B2	TT9H85R	Limited	Genetic Variation	[44]
HTR1B	TTK8CXU	Limited	Altered Expression	[45]
HTR6	TTJS8PY	Limited	Biomarker	[46]
HTT	TTIWZ0O	Limited	Biomarker	[47]
IL15RA	TTGN89I	Limited	Altered Expression	[48]
JAG2	TTOJY1B	Limited	Genetic Variation	[49]
MAOB	TTGP7BY	Limited	Biomarker	[50]
MC1R	TT0MV2T	Limited	Altered Expression	[51]
MC4R	TTD0CIQ	Limited	Biomarker	[52]
MCHR1	TTX4RTB	Limited	Biomarker	[53]
MGLL	TTZ963I	Limited	Biomarker	[54]
MKNK1	TTEZAUX	Limited	Genetic Variation	[55]
MSMB	TTYH1ZK	Limited	Biomarker	[56]
NFKB2	TTKLNRV	Limited	Biomarker	[57]
NPTX2	TTNJ5A6	Limited	Biomarker	[58]
NPY1R	TTRK9JT	Limited	Biomarker	[59]
NQO2	TTJLP0R	Limited	Genetic Variation	[60]
NR1D1	TTAD1O8	Limited	Biomarker	[61]
OPRK1	TTQW87Y	Limited	Biomarker	[62]
PDE4B	TTVIAT9	Limited	Altered Expression	[63]
PDE7B	TTWIEY9	Limited	Biomarker	[64]
PLTP	TTZF6SN	Limited	Biomarker	[65]
PMEL	TT8MK59	Limited	Biomarker	[57]
PREP	TTNGKET	Limited	Biomarker	[66]
PSMB6	TT8EPLT	Limited	Altered Expression	[67]
PYY	TTVFJLX	Limited	Biomarker	[68]
SDHD	TTVH9W8	Limited	Biomarker	[69]
SF3B1	TTL2WUI	Limited	Biomarker	[70]
SGCA	TTS9Q5V	Limited	Genetic Variation	[71]
SLC18A2	TTNZRI3	Limited	Genetic Variation	[72]
SLC1A1	TTG2A6F	Limited	Altered Expression	[73]
SLC1A3	TT8WRDA	Limited	Altered Expression	[41]
SLC33A1	TTL69WB	Limited	Biomarker	[74]
SLC38A1	TT1YE9Z	Limited	Genetic Variation	[75]
SLC6A1	TTPRKM0	Limited	Biomarker	[76]
SRD5A1	TTTU72V	Limited	Genetic Variation	[77]
TAAR1	TTIU98M	Limited	Biomarker	[78]
TACR1	TTZPO1L	Limited	Biomarker	[79]
TH	TTUHP71	Limited	Altered Expression	[80]
TPH1	TTZSJHV	Limited	Biomarker	[81]
TRPC5	TT32NQ1	Limited	Biomarker	[82]
UNC13B	TT948FC	Limited	Biomarker	[83]
GABRA5	TTNZPQ1	Disputed	Genetic Variation	[84]
GRIK1	TT0MYE2	Disputed	Biomarker	[85]
LIPA	TTS8T1M	Disputed	Genetic Variation	[86]
MBOAT4	TTSYOWR	Disputed	Biomarker	[87]
BCHE	TT3MSAO	moderate	Genetic Variation	[88]
SNCA	TT08OSU	moderate	Genetic Variation	[89]
WAS	TTE8T73	moderate	Altered Expression	[90]
ADCYAP1	TTW4LYC	Strong	Biomarker	[91]
ADCYAP1R1	TT5OREU	Strong	Biomarker	[92]
ADRA1A	TTNGILX	Strong	Biomarker	[93]
ALPL	TTMR5UV	Strong	Genetic Variation	[94]
AMD1	TTBFROQ	Strong	Biomarker	[95]
AOAH	TT2EJXQ	Strong	Biomarker	[96]
ATP1A2	TT5B6HJ	Strong	Biomarker	[97]
AVPR1A	TT4TFGN	Strong	Biomarker	[98]
AVPR1B	TTL9MHW	Strong	Genetic Variation	[99]
BPI	TTXCSDR	Strong	Biomarker	[100]
BRS3	TTKYEPM	Strong	Biomarker	[93]
C9orf72	TTA4SHR	Strong	Biomarker	[101]
CCKAR	TTCG0AL	Strong	Biomarker	[102]
CD160	TTOFEAS	Strong	Biomarker	[103]
CDCA8	TT04YCM	Strong	Genetic Variation	[104]
CNR1	TT6OEDT	Strong	Altered Expression	[105]
CNTF	TTGEM5Q	Strong	Biomarker	[106]
CRH	TTA7YIZ	Strong	Biomarker	[107]
CRHR1	TT7EFHR	Strong	Biomarker	[108]
CRHR2	TTIY658	Strong	Biomarker	[109]
CRP	TTWRN6M	Strong	Biomarker	[110]
CXCR6	TT2BVUA	Strong	Biomarker	[93]
CYP17A1	TTRA5BZ	Strong	Genetic Variation	[111]
CYP2C19	TTZ58XG	Strong	Genetic Variation	[112]
CYP2D6	TTVG215	Strong	Biomarker	[113]
DRD2	TTEX248	Strong	Biomarker	[114]
DRD3	TT4C8EA	Strong	Biomarker	[115]
EHMT1	TTOFXD7	Strong	Biomarker	[116]
ELK3	TT5OJMV	Strong	Genetic Variation	[117]
EPHA5	TTV9KOD	Strong	Genetic Variation	[118]
ERBB4	TTWALCO	Strong	Biomarker	[119]
FPR1	TT5Y4EM	Strong	Genetic Variation	[111]
GHSR	TTWDC17	Strong	Biomarker	[120]
GNRHR	TT8R70G	Strong	Biomarker	[121]
GRN	TT0LWE3	Strong	Genetic Variation	[101]
HCN1	TTNB6UQ	Strong	Biomarker	[122]
HCRT	TTU5HJP	Strong	Biomarker	[123]
HSPG2	TT5UM29	Strong	Biomarker	[124]
HTR2A	TTJQOD7	Strong	Genetic Variation	[125]
HTR2C	TTWJBZ5	Strong	Biomarker	[126]
HTR3A	TTPC4TU	Strong	Biomarker	[127]
IDO1	TTZJYKH	Strong	Biomarker	[128]
KISS1R	TT3KBZY	Strong	Genetic Variation	[129]
LPAR2	TTB7Y8I	Strong	Biomarker	[93]
LRRK2	TTK0FEA	Strong	Genetic Variation	[130]
MAP2K5	TTV3O87	Strong	Genetic Variation	[131]
MAPT	TTS87KH	Strong	Genetic Variation	[111]
MECP2	TTTAU9R	Strong	Biomarker	[132]
MVD	TTE5J6X	Strong	Genetic Variation	[133]
NISCH	TT789FN	Strong	Genetic Variation	[111]
NPSR1	TTV1C0Z	Strong	Genetic Variation	[134]
NPY2R	TTJ6WK9	Strong	Biomarker	[97]
NR3C1	TTOZRK6	Strong	Biomarker	[135]
NR3C2	TT26PHO	Strong	Biomarker	[136]
OAT	TTTSCQ2	Strong	Biomarker	[137]
OPRM1	TTKWM86	Strong	Genetic Variation	[138]
OXTR	TTSCIUP	Strong	Biomarker	[98]
PCCB	TT5LURU	Strong	Genetic Variation	[111]
PDE10A	TTJW4LU	Strong	Biomarker	[139]
PHF8	TT81PFE	Strong	Biomarker	[140]
PSEN1	TTZ3S8C	Strong	Biomarker	[141]
PSEN2	TTWN3F4	Strong	Genetic Variation	[111]
PTPRZ1	TT4SEA8	Strong	Biomarker	[142]
RAPGEF3	TTOE7I0	Strong	Altered Expression	[143]
RAPGEF4	TTOS63B	Strong	Biomarker	[143]
RGS2	TTKB7T3	Strong	Biomarker	[144]
SLC38A3	TTMAVJQ	Strong	Genetic Variation	[111]
SLC6A3	TTVBI8W	Strong	Altered Expression	[80]
SSTR4	TTAE1BR	Strong	Biomarker	[93]
STAB1	TTJFEOC	Strong	Genetic Variation	[111]
TACR3	TTBPGLU	Strong	Altered Expression	[145]
TARDBP	TT9RZ03	Strong	Altered Expression	[146]
TDO2	TTXNCBV	Strong	Biomarker	[128]
TLR9	TTSHG0T	Strong	Genetic Variation	[111]
TSPO	TTPTXIN	Strong	Biomarker	[147]
TSSK2	TTA3Z2W	Strong	Biomarker	[148]
AGRP	TT4DE1O	Definitive	Altered Expression	[149]
CASP2	TT12VNG	Definitive	Altered Expression	[150]
DAO	TT7Y3EJ	Definitive	Biomarker	[151]
DPYSL2	TTZCW3T	Definitive	Altered Expression	[152]
GABRQ	TTXDUR9	Definitive	Biomarker	[153]
GALNS	TTT9YPO	Definitive	Genetic Variation	[154]
GUCY2C	TTLDPRG	Definitive	Altered Expression	[155]
PDE2A	TTJGW1Z	Definitive	Biomarker	[156]
SLC22A2	TT0XOJN	Definitive	Genetic Variation	[157]
TRPM2	TTEBMN7	Definitive	Biomarker	[158]

This Disease Is Related to 4 DTP Molecule(s)

Gene Name	DTP ID	Evidence Level	Mode of Inheritance	REF
SLC17A8	DTAGDH7	Limited	Altered Expression	[159]
SLC26A1	DTJ785O	Limited	Genetic Variation	[75]
SLC32A1	DTXQYLR	Limited	Biomarker	[160]
SLC17A7	DTNK0FR	Definitive	Biomarker	[161]

This Disease Is Related to 14 DME Molecule(s)

Gene Name	DME ID	Evidence Level	Mode of Inheritance	REF
ADH1B	DEEN9RD	Limited	Genetic Variation	[162]
AKR1C1	DE7P2FB	Limited	Altered Expression	[77]
CES2	DETHCPD	Limited	Genetic Variation	[163]
FAAH	DEUM1EX	Limited	Biomarker	[164]
PMM2	DEBRX3L	Limited	Biomarker	[165]
PRODH	DEVJIHS	Limited	Genetic Variation	[166]
UGT2B15	DENZ6B1	Limited	Biomarker	[167]
SAT1	DEMWO83	moderate	Altered Expression	[168]
AS3MT	DE9KJP3	Strong	Genetic Variation	[111]
MSRA	DEU2ZBY	Strong	Genetic Variation	[111]
NT5C2	DE1DOKJ	Strong	Genetic Variation	[111]
PARK7	DEPOVCH	Strong	Genetic Variation	[169]
THOP1	DE95LJC	Strong	Biomarker	[170]
PER1	DE9HF0I	Definitive	Altered Expression	[171]

This Disease Is Related to 250 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
ACAD8	OT3JI5GB	Limited	Biomarker	[172]
ALDH1L1	OT15HOJX	Limited	Biomarker	[173]
ALLC	OTZE4XV7	Limited	Biomarker	[174]
ALYREF	OTOF2ADD	Limited	Biomarker	[175]
ANKK1	OT0OM1O0	Limited	Biomarker	[176]
ARC	OTN2QQPG	Limited	Biomarker	[177]
ARHGEF9	OTB1FLIW	Limited	Genetic Variation	[178]
ASCC2	OT3B204T	Limited	Biomarker	[57]
ASXL1	OTX931AW	Limited	Biomarker	[70]
BAIAP3	OTS1H0J0	Limited	Genetic Variation	[83]
BTG3	OT9ANHVT	Limited	Biomarker	[179]
CBLN2	OT29SSBE	Limited	Biomarker	[180]
CBLN4	OTO7QW6Y	Limited	Genetic Variation	[180]
CENPV	OTPQ0KT9	Limited	Altered Expression	[181]
CITED2	OT812TV7	Limited	Biomarker	[182]
COPE	OTBKHBT7	Limited	Genetic Variation	[183]
CORT	OTX3GUHB	Limited	Biomarker	[184]
CPD	OT2CS64Y	Limited	Biomarker	[185]
CPEB1	OTLCXC6H	Limited	Biomarker	[186]
CTNNBL1	OT6KLHPA	Limited	Biomarker	[187]
DBI	OT884QY9	Limited	Genetic Variation	[188]
DCX	OTISR7K3	Limited	Biomarker	[189]
DLGAP3	OT0GR2F6	Limited	Biomarker	[190]
DLK2	OT56Y83S	Limited	Genetic Variation	[191]
EAF2	OTSOET5L	Limited	Biomarker	[192]
EEF1A2	OT9Z23K5	Limited	Biomarker	[193]
ENDOU	OTB7OF7Y	Limited	Biomarker	[194]
EPRS1	OTXK0FLB	Limited	Biomarker	[195]
EXOSC6	OTAC10N6	Limited	Biomarker	[194]
FBXO7	OTGTN8TJ	Limited	Genetic Variation	[196]
FGFBP3	OTWM1KCM	Limited	Genetic Variation	[197]
FOXG1	OTAW57J4	Limited	Biomarker	[198]
GPHN	OTAKK1SV	Limited	Biomarker	[178]
GPR26	OTBDYUOH	Limited	Biomarker	[199]
HNRNPU	OTLQN1E2	Limited	Biomarker	[200]
HOMER1	OTWFD3SI	Limited	Biomarker	[201]
IFT122	OTSK3OAD	Limited	Biomarker	[202]
IGSF9B	OTNOMYYQ	Limited	Biomarker	[203]
KCNS1	OTD8GEO0	Limited	Biomarker	[204]
KPNA1	OTEMVAJ6	Limited	Biomarker	[205]
LAT2	OTWJDKIH	Limited	Biomarker	[206]
MAGED1	OT6EOLFC	Limited	Biomarker	[207]
MCIDAS	OTK1JVAH	Limited	Biomarker	[208]
MPI	OTBH6ZK1	Limited	Biomarker	[165]
MT3	OTVCZ7HI	Limited	Biomarker	[209]
MZB1	OT071TET	Limited	Biomarker	[91]
ND2	OTG9OHOX	Limited	Biomarker	[210]
NLGN3	OTKDEC1Q	Limited	Biomarker	[211]
NPAS2	OTMRT2TS	Limited	Biomarker	[212]
NPAS4	OTA3HH6W	Limited	Biomarker	[213]
NPC1	OTRIPICX	Limited	Biomarker	[214]
NPFF	OT3WXFPR	Limited	Biomarker	[215]
NRG3	OTIFZ5CT	Limited	Altered Expression	[119]
OAS3	OT6E5FYS	Limited	Biomarker	[57]
OCA2	OTDWIGBF	Limited	Altered Expression	[216]
OSR1	OTB19LEQ	Limited	Genetic Variation	[217]
PADI1	OT13WAQX	Limited	Genetic Variation	[218]
PAFAH1B1	OT9T2TCJ	Limited	Biomarker	[70]
PCSK1N	OT7ZRW2F	Limited	Altered Expression	[219]
PDIA2	OTC2WMXS	Limited	Genetic Variation	[218]
PHB2	OTCAX3AW	Limited	Biomarker	[220]
PNN	OT0HXICH	Limited	Genetic Variation	[221]
PPP1R9B	OTDCTHTT	Limited	Biomarker	[222]
PRND	OTH4EEMI	Limited	Genetic Variation	[223]
PSMG1	OTZ5I6UM	Limited	Biomarker	[224]
PTMA	OT2W4T1M	Limited	Genetic Variation	[225]
RAPH1	OTMQXW7S	Limited	Biomarker	[226]
RBM8A	OT5SR6G0	Limited	Biomarker	[227]
RCAN1	OT1MVXC7	Limited	Biomarker	[228]
RIT1	OTVNOGOH	Limited	Genetic Variation	[229]
S100A10	OTI71243	Limited	Biomarker	[194]
SART3	OTC1AM7S	Limited	Biomarker	[57]
SERPINB2	OT72QLZB	Limited	Biomarker	[230]
SHANK1	OTK8PV0S	Limited	Biomarker	[231]
SIL1	OTDI85I5	Limited	Biomarker	[220]
SND1	OTT734JN	Limited	Biomarker	[57]
SPX	OTY3G4AR	Limited	Altered Expression	[232]
SRPX	OT5B9LXS	Limited	Genetic Variation	[221]
SYN3	OTSGYNA5	Limited	Genetic Variation	[49]
TAC1	OTM842YW	Limited	Biomarker	[233]
TAOK2	OTNUMOZ1	Limited	Biomarker	[234]
TCOF1	OT4BOYTM	Limited	Biomarker	[235]
TENM1	OTSKSU4V	Limited	Altered Expression	[236]
TIA1	OTGPN3P8	Limited	Biomarker	[237]
TMEM11	OTL9HDEY	Limited	Biomarker	[165]
ASB1	OT0NZGEI	Disputed	Genetic Variation	[238]
BPIFA2	OTLFSDZD	Disputed	Biomarker	[239]
HOMER2	OT4JGKJF	Disputed	Biomarker	[240]
INSRR	OT3F75WA	Disputed	Genetic Variation	[241]
KCNIP3	OTCQPEM4	Disputed	Genetic Variation	[242]
LYPD6	OTT45DF7	Disputed	Biomarker	[243]
PSPH	OTV1PVAX	Disputed	Biomarker	[239]
PSPN	OT54LLZJ	Disputed	Biomarker	[239]
RIDA	OTW4098I	Disputed	Biomarker	[239]
STXBP3	OTTTYMAQ	Disputed	Biomarker	[239]
TTLL5	OTUKOVEM	Disputed	Biomarker	[244]
ASXL3	OTNDJWEZ	moderate	CausalMutation	[245]
CAPS2	OT45M743	moderate	Biomarker	[246]
DTNBP1	OT9UQT2S	moderate	Biomarker	[247]
HMGN1	OTSMGH99	moderate	Altered Expression	[248]
HOXB8	OTKHOD17	moderate	Biomarker	[249]
MOCOS	OT0TL3Q5	moderate	Genetic Variation	[250]
MYT1	OTC3660I	moderate	Altered Expression	[251]
NEUROD2	OTJMMX9K	moderate	Altered Expression	[252]
PAEP	OTQA0NV4	moderate	Biomarker	[253]
PBX1	OTORABGO	moderate	Altered Expression	[249]
SMCP	OTXKY794	moderate	Genetic Variation	[250]
AATK	OTVHAX5N	Strong	Genetic Variation	[111]
ACACA	OT5CQPZY	Strong	Biomarker	[254]
AGBL2	OTCX9987	Strong	Genetic Variation	[111]
AHI1	OT8K2YWY	Strong	Biomarker	[255]
ANK3	OTJ3IRBP	Strong	Biomarker	[256]
APOBEC3C	OTPL0AI1	Strong	Genetic Variation	[257]
AREL1	OTSYV9R3	Strong	Genetic Variation	[111]
ARHGAP27	OT8BSRPC	Strong	Genetic Variation	[111]
ARSI	OTIANNWW	Strong	Genetic Variation	[258]
ATF7IP	OTU6ZA7F	Strong	Genetic Variation	[259]
BAG3	OTVXYUDQ	Strong	Biomarker	[260]
BAIAP2	OT1KKMYZ	Strong	Genetic Variation	[111]
BATF2	OT4XBZC9	Strong	Biomarker	[261]
BMS1	OTEGQ8ZO	Strong	Biomarker	[254]
C1QL1	OTNQ0G3E	Strong	Biomarker	[109]
CACHD1	OTW13G4O	Strong	Genetic Variation	[111]
CACYBP	OTJMZD2T	Strong	Biomarker	[262]
CADM2	OT45PVKC	Strong	Genetic Variation	[111]
CALM2	OTNYA92F	Strong	Biomarker	[263]
CAMK2G	OTHD9KJG	Strong	Biomarker	[264]
CASP8AP2	OTTWT68S	Strong	Biomarker	[265]
CC2D1A	OTVPU04K	Strong	Altered Expression	[266]
CELF4	OT4FS4F5	Strong	Genetic Variation	[111]
CENPJ	OTZCQZN5	Strong	Biomarker	[267]
CIAO3	OT0V91PK	Strong	Biomarker	[268]
CNNM2	OTZHO8WU	Strong	Genetic Variation	[111]
CNTN3	OTC1274J	Strong	Altered Expression	[269]
COQ8A	OT1ETSA2	Strong	Genetic Variation	[111]
COX2	OTTMVBJJ	Strong	Biomarker	[210]
CPLX1	OT7UIGTP	Strong	Biomarker	[270]
CREB3L1	OT2JHIHM	Strong	Biomarker	[271]
CSTA	OT1K68KE	Strong	Biomarker	[272]
CTRL	OTB6NA5O	Strong	Biomarker	[273]
DCLRE1C	OTW3KB1I	Strong	Biomarker	[274]
DENND1A	OTONDAA0	Strong	Genetic Variation	[111]
DENND1B	OT3VCNPE	Strong	Genetic Variation	[111]
DISC1	OT43AW4H	Strong	Biomarker	[275]
DLX4	OTLWVCN4	Strong	Genetic Variation	[276]
DMTN	OTDTKPBW	Strong	Genetic Variation	[277]
DNAH1	OTDZ26FJ	Strong	Genetic Variation	[111]
DNASE1L3	OTEUIMC2	Strong	Biomarker	[278]
DSCAM	OTL7PRMK	Strong	Genetic Variation	[279]
DTD1	OT63V2KK	Strong	Genetic Variation	[111]
EBPL	OT59J1GY	Strong	Genetic Variation	[117]
ELP4	OTP5GZ9V	Strong	Genetic Variation	[111]
ERCC6L2	OTWFECWG	Strong	Genetic Variation	[279]
EYA1	OTHU807A	Strong	Genetic Variation	[104]
FAM120A	OTLAG3VN	Strong	Genetic Variation	[111]
FASTK	OTTHFZMP	Strong	Genetic Variation	[280]
FGD1	OTV3T64P	Strong	Biomarker	[281]
FLVCR1	OT9XCFOC	Strong	Biomarker	[282]
FXR1	OTEMQ1SR	Strong	Biomarker	[283]
GALR3	OTXU6PKO	Strong	Genetic Variation	[284]
GNAS	OTMH8BKJ	Strong	Genetic Variation	[49]
GPR42	OTEB0ROY	Strong	Biomarker	[93]
GTF2I	OTUYL1TQ	Strong	Genetic Variation	[285]
GYPA	OTABU4YV	Strong	Biomarker	[286]
HFE	OTDD93KB	Strong	Genetic Variation	[111]
INA	OT1D33T4	Strong	Genetic Variation	[111]
INO80C	OTKXHGET	Strong	Biomarker	[287]
INPP5K	OTQFLQKA	Strong	Biomarker	[272]
ITIH1	OTSXJGQF	Strong	Genetic Variation	[111]
ITIH3	OT4SLMLY	Strong	Genetic Variation	[111]
KANK2	OT3SZIWM	Strong	Biomarker	[262]
KAT8	OT5LPQTR	Strong	Genetic Variation	[111]
LAMA1	OTQZMP86	Strong	Genetic Variation	[288]
LTBP3	OTME98V7	Strong	Genetic Variation	[289]
MADD	OTUFYVGG	Strong	Genetic Variation	[111]
MAGI1	OTMV4ASV	Strong	Genetic Variation	[111]
MAP6	OTPUI00F	Strong	Biomarker	[290]
MBD5	OTFHT4MO	Strong	Genetic Variation	[291]
MEN1	OTN6U6V0	Strong	Genetic Variation	[292]
MMAB	OTOWOEJN	Strong	Genetic Variation	[111]
MTCH2	OTV3E4GU	Strong	Genetic Variation	[111]
NBEAL2	OTMCAXWR	Strong	Biomarker	[293]
ND6	OTG47B7B	Strong	Biomarker	[210]
NDST3	OT8TWYOG	Strong	Genetic Variation	[111]
NFIA	OTDHQ9CG	Strong	Genetic Variation	[111]
NIPBL	OTF6OOLU	Strong	Genetic Variation	[294]
NLGN2	OTHDYL3H	Strong	Altered Expression	[295]
NLGN4Y	OT7E1S57	Strong	Altered Expression	[296]
NPS	OTEG25A2	Strong	Biomarker	[297]
NPTN	OTAQKSAU	Strong	Biomarker	[298]
NSF	OTKRJ2ZT	Strong	Genetic Variation	[111]
OR2AG1	OTEITRP4	Strong	Genetic Variation	[299]
OTP	OTS0JN6Y	Strong	Biomarker	[300]
PALM	OTTZONUX	Strong	Genetic Variation	[111]
PANX1	OTXPEDOK	Strong	Altered Expression	[301]
PAX6	OTOC9876	Strong	Genetic Variation	[111]
PDSS1	OTXGVHAB	Strong	Biomarker	[302]
PEG3	OTHQW98S	Strong	Biomarker	[303]
PELI1	OTMLBCLC	Strong	Genetic Variation	[304]
PER3	OTVKYVJA	Strong	Genetic Variation	[305]
PICALM	OTQVRPMQ	Strong	Biomarker	[263]
PPM1F	OTU0MVR7	Strong	Altered Expression	[264]
PRDM6	OTKY12D9	Strong	Genetic Variation	[304]
PROS1	OTXQWNOI	Strong	Biomarker	[306]
PROX2	OTVUW0GJ	Strong	Genetic Variation	[111]
PTCH1	OTMG07H5	Strong	Genetic Variation	[111]
PVALB	OTZW1WVQ	Strong	Biomarker	[307]
RBFOX1	OTFPKEL7	Strong	Genetic Variation	[111]
RBM14	OTO9GMBD	Strong	Biomarker	[262]
RBX1	OTYA1UIO	Strong	Genetic Variation	[111]
REST	OTLL92LQ	Strong	Altered Expression	[308]
RGS1	OTGXJYMG	Strong	Genetic Variation	[309]
RPS4Y1	OTIFRF9S	Strong	Genetic Variation	[296]
RPS6KL1	OTAWSRPL	Strong	Genetic Variation	[111]
RSRC1	OTFCJ4S0	Strong	Genetic Variation	[111]
SATB2	OT2W80XC	Strong	Genetic Variation	[111]
SEPHS1	OTZ19I59	Strong	Biomarker	[302]
SGCE	OT9F17JB	Strong	Genetic Variation	[310]
SGCZ	OTVGTEOD	Strong	Genetic Variation	[111]
SLITRK5	OTTSUSB8	Strong	Biomarker	[311]
SMIM20	OTZI1KFR	Strong	Biomarker	[312]
SMR3A	OT6NAJJI	Strong	Genetic Variation	[257]
SMS	OT8JYKNH	Strong	Biomarker	[313]
SNAP91	OTE3EXWZ	Strong	Biomarker	[263]
SOSTDC1	OTAKDNSM	Strong	Biomarker	[314]
SPI1	OTVCA1D0	Strong	Genetic Variation	[111]
STIMATE	OTEDLKEW	Strong	Genetic Variation	[111]
STX2	OTO2IDDR	Strong	Biomarker	[302]
SYNGR1	OT0MBUK5	Strong	Biomarker	[63]
TBX4	OTW58FG4	Strong	Biomarker	[302]
TMEM132D	OTV6I4Z0	Strong	Biomarker	[315]
TP53INP1	OT2363Z9	Strong	Biomarker	[262]
TSACC	OT3QW6PH	Strong	Biomarker	[262]
TSKU	OT1XMRIM	Strong	Genetic Variation	[316]
TSNARE1	OTTJHX9A	Strong	Genetic Variation	[111]
TSSK1B	OTRATM7R	Strong	Biomarker	[148]
ADA2	OTGCV24S	Definitive	Genetic Variation	[317]
ADAMTS2	OTTK22NO	Definitive	Biomarker	[318]
BLOC1S4	OTDCFUJC	Definitive	Biomarker	[319]
CASKIN1	OTQ9I0QU	Definitive	Biomarker	[320]
CPZ	OT5HUR28	Definitive	Altered Expression	[321]
CRYGD	OTW29JC4	Definitive	Biomarker	[322]
DUSP26	OTI7WIYN	Definitive	Biomarker	[323]
FMR1	OTWEV0T5	Definitive	Genetic Variation	[324]
NANOS1	OT3UNZZY	Definitive	Genetic Variation	[325]
NR2F1	OTGWZWYL	Definitive	Biomarker	[326]
P4HTM	OTKELL7F	Definitive	Altered Expression	[327]
PAGR1	OTXR5PQ8	Definitive	Genetic Variation	[154]
TMEM59	OTX4EKES	Definitive	Biomarker	[328]
TMPRSS13	OTMAOAP3	Definitive	Biomarker	[56]

References

• [1] Alprazolam FDA Label
• [2] Chlordiazepoxide FDA Label
• [3] Citalopram FDA Label
• [4] Clorazepate FDA Label
• [5] Diazepam FDA Label
• [6] Doxepin FDA Label
• [7] Ketamine FDA Label
• [8] Lorazepam FDA Label
• [9] Meprobamate FDA Label
• [10] Methamphetamine FDA Label
• [11] Psycho-pharmacotherapy for anxiety and obsessive-compulsive disorder: the issue of prolonged barbiturate retention. Curr Med Res Opin. 2009 Sep;25(9):2281-5.
• [12] Midazolam FDA Label
• [13] Oxazepam FDA Label
• [14] Oxprenolol FDA Label
• [15] Prazepam FDA Label
• [16] Trifluoperazine FDA Label
• [17] Alpha2B-Adrenergic Receptor Overexpression in the Brain Potentiate Air Pollution-induced Behavior and Blood Pressure Changes.Toxicol Sci. 2019 May 1;169(1):95-107. doi: 10.1093/toxsci/kfz025.
• [18] Apelin-13 enhances contextual fear extinction in rats.Neurosci Lett. 2019 Nov 1;712:134487. doi: 10.1016/j.neulet.2019.134487. Epub 2019 Sep 9.
• [19] Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood.Mol Psychiatry. 2018 Mar;23(3):533-543. doi: 10.1038/mp.2017.133. Epub 2017 Jul 11.
• [20] Autophosphorylation of CaMKK2 generates autonomous activity that is disrupted by a T85S mutation linked to anxiety and bipolar disorder.Sci Rep. 2015 Sep 23;5:14436. doi: 10.1038/srep14436.
• [21] Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat.Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jan 10;96:109761. doi: 10.1016/j.pnpbp.2019.109761. Epub 2019 Sep 14.
• [22] The Edinburgh Postpartum Depression Scale: Stable structure but subscale of limited value to detect anxiety.PLoS One. 2019 Sep 9;14(9):e0221894. doi: 10.1371/journal.pone.0221894. eCollection 2019.
• [23] Thalamic Control of Cognition and Social Behavior Via Regulation of Gamma-Aminobutyric Acidergic Signaling and Excitation/Inhibition Balance in the Medial Prefrontal Cortex.Biol Psychiatry. 2018 Apr 15;83(8):657-669. doi: 10.1016/j.biopsych.2017.11.033. Epub 2017 Dec 7.
• [24] Candidate genes for nicotine dependence via linkage, epistasis, and bioinformatics.Am J Med Genet B Neuropsychiatr Genet. 2004 Apr 1;126B(1):23-36. doi: 10.1002/ajmg.b.20138.
• [25] Alpha-7 nicotinic receptor allosteric modulator PNU120596 prevents lipopolysaccharide-induced anxiety, cognitive deficit and depression-like behaviors in mice.Behav Brain Res. 2019 Jul 2;366:19-28. doi: 10.1016/j.bbr.2019.03.019. Epub 2019 Mar 12.
• [26] miR-219 attenuates demyelination in cuprizone-induced demyelinated mice by regulating monocarboxylate transporter 1.Eur J Neurosci. 2017 Jan;45(2):249-259. doi: 10.1111/ejn.13485.
• [27] A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypes.J Affect Disord. 2019 Oct 1;257:716-722. doi: 10.1016/j.jad.2019.07.083. Epub 2019 Jul 30.
• [28] Psychological and emotional development, intellectual capabilities, and body image in short normal children.J Endocrinol Invest. 2002 Apr;25(4):321-8. doi: 10.1007/BF03344012.
• [29] Common genetic origins for EEG, alcoholism and anxiety: the role of CRH-BP.PLoS One. 2008;3(10):e3620. doi: 10.1371/journal.pone.0003620. Epub 2008 Oct 31.
• [30] Dyrk1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice.Sci Rep. 2017 Apr 4;7(1):619. doi: 10.1038/s41598-017-00682-y.
• [31] Intranasal fentanyl and inhaled nitrous oxide for fracture reduction: The FAN observational study.Am J Emerg Med. 2017 May;35(5):710-715. doi: 10.1016/j.ajem.2017.01.004. Epub 2017 Jan 5.
• [32] Hsp90 Heterocomplexes Regulate Steroid Hormone Receptors: From Stress Response to Psychiatric Disease.Int J Mol Sci. 2018 Dec 25;20(1):79. doi: 10.3390/ijms20010079.
• [33] Preliminary Data on Some Behavioral Changes Induced by Short-Term Intraperitoneal Oxytocin Administration in Aged Rats.Psychiatr Danub. 2018 Mar;30(1):91-98. doi: 10.24869/psyd.2018.91.
• [34] Developmental seizures and mortality result from reducing GABA(A) receptor 2-subunit interaction with collybistin.Nat Commun. 2018 Aug 7;9(1):3130. doi: 10.1038/s41467-018-05481-1.
• [35] Dorsal hippocampal galanin modulates anxiety-like behaviours in rats.Brain Res. 2018 May 15;1687:74-81. doi: 10.1016/j.brainres.2018.02.036. Epub 2018 Feb 27.
• [36] A Novel Integrative Mechanism in Anxiolytic Behavior Induced by Galanin 2/Neuropeptide Y Y1 Receptor Interactions on Medial Paracapsular Intercalated Amygdala in Rats.Front Cell Neurosci. 2018 May 1;12:119. doi: 10.3389/fncel.2018.00119. eCollection 2018.
• [37] GPER1/GPR30 in the brain: Crosstalk with classical estrogen receptors and implications for behavior.J Steroid Biochem Mol Biol. 2018 Feb;176:57-64. doi: 10.1016/j.jsbmb.2017.04.012. Epub 2017 Apr 29.
• [38] No association of GPNMB rs156429 polymorphism with Parkinson's disease, amyotrophic lateral sclerosis and multiple system atrophy in Chinese population.Neurosci Lett. 2016 May 27;622:113-7. doi: 10.1016/j.neulet.2016.04.060. Epub 2016 Apr 27.
• [39] The novel cannabinoid receptor GPR55 mediates anxiolytic-like effects in the medial orbital cortex of mice with acute stress.Mol Brain. 2017 Aug 11;10(1):38. doi: 10.1186/s13041-017-0318-7.
• [40] Amygdala levels of the GluA1 subunit of glutamate receptors and its phosphorylation state at serine 845 in the anterior hippocampus are biomarkers of ictal fear but not anxiety.Mol Psychiatry. 2020 Mar;25(3):655-665. doi: 10.1038/s41380-018-0084-7. Epub 2018 Jun 7.
• [41] The effects of alcoholism on the human basolateral amygdala.Neuroscience. 2010 May 5;167(2):361-71. doi: 10.1016/j.neuroscience.2010.01.061. Epub 2010 Feb 11.
• [42] An Appraisal of the Influence of the Metabotropic Glutamate 5 (mGlu5) Receptor on Sociability and Anxiety.Front Mol Neurosci. 2019 Feb 19;12:30. doi: 10.3389/fnmol.2019.00030. eCollection 2019.
• [43] Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes.Transl Psychiatry. 2019 Feb 4;9(1):75. doi: 10.1038/s41398-019-0415-8.
• [44] The Role of 11-Hydroxy Steroid Dehydrogenase Type 2 in Glucocorticoid Programming of Affective and Cognitive Behaviours.Neuroendocrinology. 2019;109(3):257-265. doi: 10.1159/000499660. Epub 2019 Mar 19.
• [45] Serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder in Chinese Han subjects.Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5;132B(1):59-63. doi: 10.1002/ajmg.b.30075.
• [46] Dorsomedial prefrontal cortex 5-HT6 receptors regulate anxiety-like behavior.Cogn Affect Behav Neurosci. 2018 Feb;18(1):58-67. doi: 10.3758/s13415-017-0552-6.
• [47] Huntingtin gene repeat size variations affect risk of lifetime depression.Transl Psychiatry. 2017 Dec 11;7(12):1277. doi: 10.1038/s41398-017-0042-1.
• [48] Hippocampus-specific deficiency of IL-15R contributes to greater anxiety-like behaviors in mice.Metab Brain Dis. 2017 Apr;32(2):297-302. doi: 10.1007/s11011-016-9930-y. Epub 2016 Nov 11.
• [49] A multi-dimensional characterization of anxiety in monozygotic twin pairs reveals susceptibility loci in humans.Transl Psychiatry. 2017 Dec 11;7(12):1282. doi: 10.1038/s41398-017-0047-9.
• [50] Perseveration in a spatial-discrimination serial reversal learning task is differentially affected by MAO-A and MAO-B inhibition and associated with reduced anxiety and peripheral serotonin levels.Psychopharmacology (Berl). 2017 May;234(9-10):1557-1571. doi: 10.1007/s00213-017-4569-x. Epub 2017 Mar 2.
• [51] Anesthetic efficacy of the inferior alveolar nerve block in red-haired women.J Endod. 2012 Dec;38(12):1564-9. doi: 10.1016/j.joen.2012.08.014. Epub 2012 Oct 3.
• [52] Exercise Attenuates Anabolic Steroids-Induced Anxiety via Hippocampal NPY and MC4 Receptor in Rats.Front Neurosci. 2019 Feb 26;13:172. doi: 10.3389/fnins.2019.00172. eCollection 2019.
• [53] Anti-obesity effects of small molecule melanin-concentrating hormone receptor 1 (MCHR1) antagonists.Life Sci. 2007 Jul 19;81(6):423-40. doi: 10.1016/j.lfs.2007.05.029. Epub 2007 Jun 27.
• [54] Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats.Int J Neuropsychopharmacol. 2019 Feb 1;22(2):165-172. doi: 10.1093/ijnp/pyy086.
• [55] Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E.Nat Commun. 2018 Jun 25;9(1):2459. doi: 10.1038/s41467-018-04883-5.
• [56] Pharmacotherapy for mood and anxiety disorders in older people with intellectual disability in comparison with the general population.BMC Psychiatry. 2019 Aug 1;19(1):238. doi: 10.1186/s12888-019-2191-7.
• [57] A Rodent Model of Anxiety: The Effect of Perinatal Immune Challenges on Gastrointestinal Inflammation and Integrity.Neuroimmunomodulation. 2018;25(3):163-175. doi: 10.1159/000493320. Epub 2018 Nov 9.
• [58] NPTX2 is a key component in the regulation of anxiety.Neuropsychopharmacology. 2018 Aug;43(9):1943-1953. doi: 10.1038/s41386-018-0091-z. Epub 2018 May 11.
• [59] Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the amygdala lead to increased anxiolytic actions.Brain Struct Funct. 2015 Jul;220(4):2289-301. doi: 10.1007/s00429-014-0788-7. Epub 2014 May 20.
• [60] Loss of quinone reductase 2 function selectively facilitates learning behaviors.J Neurosci. 2010 Sep 22;30(38):12690-700. doi: 10.1523/JNEUROSCI.2808-10.2010.
• [61] The circadian gene Nr1d1 in the mouse nucleus accumbens modulates sociability and anxiety-related behavior.Eur J Neurosci. 2018 Oct 16. doi: 10.1111/ejn.14207. Online ahead of print.
• [62] Activation of kappa opioid receptors in the dorsal raphe have sex dependent effects on social behavior in California mice.Behav Brain Res. 2018 Oct 1;351:83-92. doi: 10.1016/j.bbr.2018.05.011. Epub 2018 Jun 7.
• [63] Expression and significance of phosphodiesterase 4B gene in peripheral blood of patients with oral lichen planus.Int J Dermatol. 2019 Mar;58(3):302-310. doi: 10.1111/ijd.14203. Epub 2018 Sep 19.
• [64] Phosphodiesterase-7 inhibition affects accumbal and hypothalamic thyrotropin-releasing hormone expression, feeding and anxiety behavior of rats.Behav Brain Res. 2017 Feb 15;319:165-173. doi: 10.1016/j.bbr.2016.11.027. Epub 2016 Nov 15.
• [65] Brain Vitamin E Deficiency During Development Is Associated With Increased Glutamate Levels and Anxiety in Adult Mice.Front Behav Neurosci. 2018 Dec 11;12:310. doi: 10.3389/fnbeh.2018.00310. eCollection 2018.
• [66] Contagious Anxiety: Anxious European Americans Can Transmit Their Physiological Reactivity to African Americans.Psychol Sci. 2017 Dec;28(12):1796-1806. doi: 10.1177/0956797617722551. Epub 2017 Nov 6.
• [67] 15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse.Neuropharmacology. 2014 Jan;76 Pt B(0 0):204-17. doi: 10.1016/j.neuropharm.2013.08.028. Epub 2013 Sep 10.
• [68] Appetite Perceptions, Gastrointestinal Symptoms, Ghrelin, Peptide YY and State Anxiety Are Disturbed in Adolescent Females with Anorexia Nervosa and Only Partially Restored with Short-Term Refeeding.Nutrients. 2018 Dec 28;11(1):59. doi: 10.3390/nu11010059.
• [69] Attention Deficit Hyperactivity Disorder in Pediatric Patients with Pheochromocytoma and Paraganglioma.Horm Metab Res. 2016 Aug;48(8):509-13. doi: 10.1055/s-0042-106725. Epub 2016 May 12.
• [70] Impacts of dance on cognition, psychological symptoms and quality of life in Parkinson's disease.NeuroRehabilitation. 2019;45(2):273-283. doi: 10.3233/NRE-192788.
• [71] Self-reported physical activity levels and clinical progression in early Parkinson's disease.Parkinsonism Relat Disord. 2019 Apr;61:118-125. doi: 10.1016/j.parkreldis.2018.11.006. Epub 2018 Dec 10.
• [72] A Functional Vesicular Monoamine Transporter 1 (VMAT1) Gene Variant Is Associated with Affect and the Prevalence of Anxiety, Affective, and Alcohol Use Disorders in a Longitudinal Population-Representative Birth Cohort Study.Int J Neuropsychopharmacol. 2016 Jul 5;19(7):pyw013. doi: 10.1093/ijnp/pyw013. Print 2016 Jul.
• [73] Neurochemical and behavioral characterization of neuronal glutamate transporter EAAT3 heterozygous mice.Biol Res. 2017 Sep 19;50(1):29. doi: 10.1186/s40659-017-0138-3.
• [74] Angiotensin as stress mediator: role of its receptor and interrelationships among other stress mediators and receptors.Pharmacol Res. 2013 Oct;76:49-57. doi: 10.1016/j.phrs.2013.07.004. Epub 2013 Jul 24.
• [75] Positive association between SAT-1 -1415T/C polymorphism and anxiety.Am J Med Genet B Neuropsychiatr Genet. 2009 Jun 5;150B(4):515-9. doi: 10.1002/ajmg.b.30850.
• [76] Studies on the Activity of Selected Highly Lipophilic Compounds toward hGAT1 Inhibition. Part II.ACS Chem Neurosci. 2019 Jan 16;10(1):337-347. doi: 10.1021/acschemneuro.8b00282. Epub 2018 Sep 28.
• [77] Gender-specific association of variants in the AKR1C1 gene with dimensional anxiety in patients with panic disorder: additional evidence for the importance of neurosteroids in anxiety?.Depress Anxiety. 2014 Oct;31(10):843-50. doi: 10.1002/da.22229. Epub 2014 Jan 3.
• [78] The Case for TAAR1 as a Modulator of Central Nervous System Function.Front Pharmacol. 2018 Jan 10;8:987. doi: 10.3389/fphar.2017.00987. eCollection 2017.
• [79] Alcohol-induced conditioned place preference negatively correlates with anxiety-like behavior in adolescent mice: inhibition by a neurokinin-1 receptor antagonist.Psychopharmacology (Berl). 2018 Oct;235(10):2847-2857. doi: 10.1007/s00213-018-4976-7. Epub 2018 Jul 27.
• [80] Modulation of Hippocampal Antioxidant Defense System in Chronically Stressed Rats by Lithium.Oxid Med Cell Longev. 2019 Feb 17;2019:8745376. doi: 10.1155/2019/8745376. eCollection 2019.
• [81] Association analysis of monoamine genes with measures of depression and anxiety in a selected community sample of siblings.Am J Med Genet B Neuropsychiatr Genet. 2005 May 5;135B(1):33-7. doi: 10.1002/ajmg.b.30063.
• [82] Properties and therapeutic potential of transient receptor potential channels with putative roles in adversity: focus on TRPC5, TRPM2 and TRPA1.Curr Drug Targets. 2011 May;12(5):724-36. doi: 10.2174/138945011795378568.
• [83] Genetic markers of a Munc13 protein family member, BAIAP3, are gender specifically associated with anxiety and benzodiazepine abuse in mice and humans.Mol Med. 2013 Jul 24;19(1):135-48. doi: 10.2119/molmed.2013.00033.
• [84] Decreasing the Expression of GABA(A) 5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome.Mol Neurobiol. 2018 Jun;55(6):4745-4762. doi: 10.1007/s12035-017-0675-3. Epub 2017 Jul 17.
• [85] Kainate receptor mediated presynaptic LTP in agranular insular cortex contributes to fear and anxiety in mice.Neuropharmacology. 2018 Jan;128:388-400. doi: 10.1016/j.neuropharm.2017.10.037. Epub 2017 Nov 12.
• [86] Religiosity prevalence and its association with depression and anxiety symptoms among Hispanic/Latino adults.PLoS One. 2018 Feb 7;13(2):e0185661. doi: 10.1371/journal.pone.0185661. eCollection 2018.
• [87] Desacyl Ghrelin Decreases Anxiety-like Behavior in Male Mice.Endocrinology. 2018 Jan 1;159(1):388-399. doi: 10.1210/en.2017-00540.
• [88] Mobile phone induced cognitive and neurochemical consequences.J Chem Neuroanat. 2019 Dec;102:101684. doi: 10.1016/j.jchemneu.2019.101684. Epub 2019 Sep 22.
• [89] Ethanol (EtOH)-Related Behaviors in -Synuclein Mutant Mice and Association of SNCA SNPs with Anxiety in EtOH-Dependent Patients.Alcohol Clin Exp Res. 2018 Nov;42(11):2172-2185. doi: 10.1111/acer.13875. Epub 2018 Sep 5.
• [90] Functional effects of synthetic cannabinoids versus (9) -THC in mice on body temperature, nociceptive threshold, anxiety, cognition, locomotor/exploratory parameters and depression.Addict Biol. 2019 May;24(3):414-425. doi: 10.1111/adb.12606. Epub 2018 Feb 8.
• [91] PACAP neurons in the ventral premammillary nucleus regulate reproductive function in the female mouse.Elife. 2018 Jun 15;7:e35960. doi: 10.7554/eLife.35960.
• [92] ADCYAP1R1 and asthma in Puerto Rican children.Am J Respir Crit Care Med. 2013 Mar 15;187(6):584-8. doi: 10.1164/rccm.201210-1789OC. Epub 2013 Jan 17.
• [93] RGS2 ggenetic variation: association analysis with panic disorder and dimensional as well as intermediate phenotypes of anxiety.Am J Med Genet B Neuropsychiatr Genet. 2015 Apr;168B(3):211-22. doi: 10.1002/ajmg.b.32299. Epub 2015 Mar 4.
• [94] Overexpression of tissue-nonspecific alkaline phosphatase increases the expression of neurogenic differentiation markers in the human SH-SY5Y neuroblastoma cell line.Bone. 2015 Oct;79:150-61. doi: 10.1016/j.bone.2015.05.033. Epub 2015 May 29.
• [95] Profiles and Predictors of Infant Sleep Problems Across the First Year.J Dev Behav Pediatr. 2020 Feb/Mar;41(2):104-116. doi: 10.1097/DBP.0000000000000733.
• [96] Acyloxyacyl hydrolase modulates depressive-like behaviors through aryl hydrocarbon receptor.Am J Physiol Regul Integr Comp Physiol. 2019 Aug 1;317(2):R289-R300. doi: 10.1152/ajpregu.00029.2019. Epub 2019 Apr 24.
• [97] Ulk4 regulates GABAergic signaling and anxiety-related behavior.Transl Psychiatry. 2018 Feb 2;8(1):43. doi: 10.1038/s41398-017-0091-5.
• [98] Maternal stress during pregnancy induces depressive-like behavior only in female offspring and correlates to their hippocampal Avp and Oxt receptor expression.Behav Brain Res. 2018 Nov 1;353:1-10. doi: 10.1016/j.bbr.2018.06.027. Epub 2018 Jun 26.
• [99] Family-based study of AVPR1B association and interaction with stressful life events on depression and anxiety in suicide attempts.Neuropsychopharmacology. 2013 Jul;38(8):1504-11. doi: 10.1038/npp.2013.49. Epub 2013 Feb 19.
• [100] A Pilot Randomized Controlled Trial of a Guided Self-Help Intervention to Manage Chronic Orofacial Pain.J Oral Facial Pain Headache. 2017 Winter;31(1):61-71. doi: 10.11607/ofph.1665.
• [101] Distinct Neuroanatomical Correlates of Neuropsychiatric Symptoms in the Three Main Forms of Genetic Frontotemporal Dementia in the GENFI Cohort.J Alzheimers Dis. 2018;65(1):147-163. doi: 10.3233/JAD-180053.
• [102] Cholecystokinin system genes: associations with panic and other psychiatric disorders.J Affect Disord. 2012 Feb;136(3):902-8. doi: 10.1016/j.jad.2011.09.011. Epub 2011 Oct 5.
• [103] Down-regulation of amygdala preprotachykinin A mRNA but not 3H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia. Eur J Neurosci. 2005 Mar;21(6):1712-8. doi: 10.1111/j.1460-9568.2005.04002.x.
• [104] Genome-wide analyses of borderline personality features.Mol Psychiatry. 2014 Aug;19(8):923-9. doi: 10.1038/mp.2013.109. Epub 2013 Aug 27.
• [105] Early intervention with electroacupuncture prevents PTSD-like behaviors in rats through enhancing hippocampal endocannabinoid signaling.Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jul 13;93:171-181. doi: 10.1016/j.pnpbp.2019.03.018. Epub 2019 Apr 1.
• [106] Ciliary neurotrophic factor is a key sex-specific regulator of depressive-like behavior in mice.Psychoneuroendocrinology. 2019 Feb;100:96-105. doi: 10.1016/j.psyneuen.2018.09.038. Epub 2018 Sep 29.
• [107] Toxicity of Pexacerfont, a Corticotropin-Releasing Factor Type 1 Receptor Antagonist, in Rats and Dogs.Int J Toxicol. 2019 Mar/Apr;38(2):110-120. doi: 10.1177/1091581819827501. Epub 2019 Feb 13.
• [108] Blocking CRH receptors in adults mitigates age-related memory impairments provoked by early-life adversity.Neuropsychopharmacology. 2020 Feb;45(3):515-523. doi: 10.1038/s41386-019-0562-x. Epub 2019 Nov 7.
• [109] Helicobacter pylori Vacuolating Cytotoxin A Causes Anorexia and Anxiety via Hypothalamic Urocortin 1 in Mice.Sci Rep. 2019 Apr 12;9(1):6011. doi: 10.1038/s41598-019-42163-4.
• [110] Biological and psychosocial predictors of anxiety worsening in the postpartum period: A longitudinal study.J Affect Disord. 2019 May 1;250:218-225. doi: 10.1016/j.jad.2019.02.064. Epub 2019 Mar 1.
• [111] Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways.Nat Genet. 2018 Jul;50(7):920-927. doi: 10.1038/s41588-018-0151-7. Epub 2018 Jun 25.
• [112] Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders.Front Pharmacol. 2019 Feb 19;10:99. doi: 10.3389/fphar.2019.00099. eCollection 2019.
• [113] A logistic equation to determine the validity of tramadol from related gene polymorphisms and psychological factors.Pharmacogenomics. 2014 Mar;15(4):487-95. doi: 10.2217/pgs.14.22.
• [114] Role of Dopamine D2 Receptor in Stress-Induced Myelin Loss.Sci Rep. 2017 Sep 14;7(1):11654. doi: 10.1038/s41598-017-10173-9.
• [115] Effects of ovarian hormones on emotional behaviors in dopamine D3 receptor knockout mice.Physiol Behav. 2019 Jan 1;198:11-17. doi: 10.1016/j.physbeh.2018.10.003. Epub 2018 Oct 4.
• [116] Chronic Suppression of Glucagon-Like Peptide-1 Receptor (GLP1R) mRNA Translation in the Rat Bed Nucleus of the Stria Terminalis Reduces Anxiety-Like Behavior and Stress-Induced Hypophagia, But Prolongs Stress-Induced Elevation of Plasma Corticosterone.J Neurosci. 2019 Apr 3;39(14):2649-2663. doi: 10.1523/JNEUROSCI.2180-18.2019. Epub 2019 Jan 25.
• [117] The effect of expressive writing on the error-related negativity among individuals with chronic worry.Psychophysiology. 2018 Feb;55(2):10.1111/psyp.12990. doi: 10.1111/psyp.12990. Epub 2017 Sep 8.
• [118] Influence of genetic factors on long-term treatment related neurocognitive complications, and on anxiety and depression in survivors of childhood acute lymphoblastic leukemia: The Petale study.PLoS One. 2019 Jun 10;14(6):e0217314. doi: 10.1371/journal.pone.0217314. eCollection 2019.
• [119] Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence.Mol Psychiatry. 2014 Jul;19(7):801-10. doi: 10.1038/mp.2013.104. Epub 2013 Sep 3.
• [120] A ghrelin receptor and oxytocin receptor heterocomplex impairs oxytocin mediated signalling.Neuropharmacology. 2019 Jul 1;152:90-101. doi: 10.1016/j.neuropharm.2018.12.022. Epub 2018 Dec 21.
• [121] More than reproduction: Central gonadotropin-releasing hormone antagonism decreases maternal aggression in lactating rats.J Neuroendocrinol. 2019 Sep;31(9):e12709. doi: 10.1111/jne.12709. Epub 2019 Apr 4.
• [122] Applying ketamine to alleviate the PTSD-like effects by regulating the HCN1-related BDNF.Prog Neuropsychopharmacol Biol Psychiatry. 2018 Aug 30;86:313-321. doi: 10.1016/j.pnpbp.2018.03.019. Epub 2018 Mar 27.
• [123] Orexin/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: Potential for therapy.Brain Res. 2020 Mar 15;1731:146085. doi: 10.1016/j.brainres.2018.12.036. Epub 2018 Dec 24.
• [124] PLC-beta1 knockout mice as a model of disrupted cortical development and plasticity: behavioral endophenotypes and dysregulation of RGS4 gene expression.Hippocampus. 2008;18(8):824-34. doi: 10.1002/hipo.20443.
• [125] Serotonin 2A receptor (5-HT2A) gene promoter variant interacts with chronic perceived stress to modulate resting parasympathetic activity in humans.Psychoneuroendocrinology. 2017 Feb;76:119-126. doi: 10.1016/j.psyneuen.2016.11.015. Epub 2016 Nov 16.
• [126] Role of 5-HT2C receptors of the dorsal hippocampus in the modulation of anxiety- and panic-related defensive responses in rats.Neuropharmacology. 2019 Apr;148:311-319. doi: 10.1016/j.neuropharm.2019.01.026. Epub 2019 Jan 25.
• [127] Response of Htr3a knockout mice to antidepressant treatment and chronic stress.Br J Pharmacol. 2017 Aug;174(15):2471-2483. doi: 10.1111/bph.13857. Epub 2017 Jul 5.
• [128] Effects of IDO1 and TDO2 inhibition on cognitive deficits and anxiety following LPS-induced neuroinflammation. Acta Neuropsychiatr. 2020 Feb;32(1):43-53.
• [129] Altered aspects of anxiety-related behavior in kisspeptin receptor-deleted male mice.Sci Rep. 2018 Feb 12;8(1):2794. doi: 10.1038/s41598-018-21042-4.
• [130] Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2.Parkinsonism Relat Disord. 2014 Oct;20(10):1097-100. doi: 10.1016/j.parkreldis.2014.07.005. Epub 2014 Jul 30.
• [131] The effects of a MAP2K5 microRNA target site SNP on risk for anxiety and depressive disorders.Am J Med Genet B Neuropsychiatr Genet. 2014 Mar;165B(2):175-83. doi: 10.1002/ajmg.b.32219. Epub 2014 Jan 16.
• [132] Loss of MeCP2 in adult 5-HT neurons induces 5-HT1A autoreceptors, with opposite sex-dependent anxiety and depression phenotypes.Sci Rep. 2018 Apr 10;8(1):5788. doi: 10.1038/s41598-018-24167-8.
• [133] The long-term effects of microvascular decompression on social phobia and health-related quality of life in patients with hemifacial spasm: a 3-year prospective study.Acta Neurochir (Wien). 2019 Oct;161(10):2035-2042. doi: 10.1007/s00701-019-04023-y. Epub 2019 Jul 31.
• [134] Investigating the Contribution of NPSR1, IL-6 and BDNF Polymorphisms to Depressive and Anxiety Symptoms in Hemodialysis Patients.Prog Neuropsychopharmacol Biol Psychiatry. 2019 Aug 30;94:109657. doi: 10.1016/j.pnpbp.2019.109657. Epub 2019 May 25.
• [135] Ablation of glucocorticoid receptor in the hindbrain of the mouse provides a novel model to investigate stress disorders.Sci Rep. 2019 Mar 1;9(1):3250. doi: 10.1038/s41598-019-39867-y.
• [136] Sleep-EEG in patients with primary aldosteronism in comparison to healthy controls and patients with depression.J Psychiatr Res. 2019 May;112:52-60. doi: 10.1016/j.jpsychires.2019.02.020. Epub 2019 Feb 23.
• [137] Insomnia and excessive daytime sleepiness in women and men receiving methadone and buprenorphine maintenance treatment.Subst Use Misuse. 2019;54(10):1589-1598. doi: 10.1080/10826084.2018.1552298. Epub 2019 May 26.
• [138] Interaction between the Opioid Receptor OPRM1 Gene and Mother-Child Language Style Matching Prospectively Predicts Children's Separation Anxiety Disorder Symptoms.Res Dev Disabil. 2018 Nov;82:120-131. doi: 10.1016/j.ridd.2018.03.002. Epub 2018 Mar 22.
• [139] Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms.Transl Psychiatry. 2011 May 24;1(5):e9. doi: 10.1038/tp.2011.9.
• [140] Phf8 loss confers resistance to depression-like and anxiety-like behaviors in mice.Nat Commun. 2017 May 9;8:15142. doi: 10.1038/ncomms15142.
• [141] Deficits in Enrichment-Dependent Neurogenesis and Enhanced Anxiety Behaviors Mediated by Expression of Alzheimer's Disease-Linked Ps1 Variants Are Rescued by Microglial Depletion.J Neurosci. 2019 Aug 21;39(34):6766-6780. doi: 10.1523/JNEUROSCI.0884-19.2019. Epub 2019 Jun 19.
• [142] Loss-of-function of PTPR and , observed in sporadic schizophrenia, causes brain region-specific deregulation of monoamine levels and altered behavior in mice.Psychopharmacology (Berl). 2017 Feb;234(4):575-587. doi: 10.1007/s00213-016-4490-8. Epub 2016 Dec 26.
• [143] Anxiety and depression with neurogenesis defects in exchange protein directly activated by cAMP 2-deficient mice are ameliorated by a selective serotonin reuptake inhibitor, Prozac.Transl Psychiatry. 2016 Sep 6;6(9):e881. doi: 10.1038/tp.2016.129.
• [144] Interplay between RGS2 and childhood adversities in predicting anxiety and depressive disorders: Findings from a general population sample.Depress Anxiety. 2018 Nov;35(11):1104-1113. doi: 10.1002/da.22812. Epub 2018 Aug 14.
• [145] Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington's disease.Hum Mol Genet. 2013 Sep 1;22(17):3485-97. doi: 10.1093/hmg/ddt203. Epub 2013 May 22.
• [146] Associations between Comorbid TDP-43, Lewy Body Pathology, and Neuropsychiatric Symptoms in Alzheimer's Disease.J Alzheimers Dis. 2019;69(4):953-961. doi: 10.3233/JAD-181285.
• [147] Do family functioning and mothers' and children's stress increase the odds of probable sleep bruxism among schoolchildren? A case control study.Clin Oral Investig. 2020 Feb;24(2):1025-1033. doi: 10.1007/s00784-019-02997-8. Epub 2019 Jul 8.
• [148] Kinesiophobia and depression affect total knee arthroplasty outcome in a multivariate analysis of psychological and physical factors on 200 patients.Knee Surg Sports Traumatol Arthrosc. 2017 Nov;25(11):3417-3423. doi: 10.1007/s00167-016-4201-3. Epub 2016 Jun 21.
• [149] AGRP neurons modulate fasting-induced anxiolytic effects.Transl Psychiatry. 2019 Mar 8;9(1):111. doi: 10.1038/s41398-019-0438-1.
• [150] Caspase-2 promotes AMPA receptor internalization and cognitive flexibility via mTORC2-AKT-GSK3 signaling.Nat Commun. 2019 Aug 9;10(1):3622. doi: 10.1038/s41467-019-11575-1.
• [151] The association of schizophrenia risk D-amino acid oxidase polymorphisms with sensorimotor gating, working memory and personality in healthy males.Neuropsychopharmacology. 2011 Jul;36(8):1677-88. doi: 10.1038/npp.2011.49. Epub 2011 Apr 6.
• [152] Effect of lacosamide on ethanol induced conditioned place preference and withdrawal associated behavior in mice: Possible contribution of hippocampal CRMP-2.Pharmacol Rep. 2019 Oct;71(5):804-810. doi: 10.1016/j.pharep.2019.04.009. Epub 2019 Apr 15.
• [153] Anxiety process "theta" biomarker in the stop signal task eliminated by a preceding relaxation test.Behav Neurosci. 2020 Dec;134(6):556-561. doi: 10.1037/bne0000328. Epub 2019 Jun 20.
• [154] Measuring Anxiety in Older Adults: Development, Diagnostic Accuracy, and Preliminary Validation of a Short-Form of the German Geriatric Anxiety Scale (GAS-G-SF).J Pers Assess. 2020 Mar-Apr;102(2):196-204. doi: 10.1080/00223891.2019.1677679. Epub 2019 Oct 18.
• [155] Anxiety-like behavior in female mice changes by feeding, possible effect of guanylate cyclase C.Eur J Neurosci. 2020 Jul;52(1):2781-2790. doi: 10.1111/ejn.14607. Epub 2019 Nov 28.
• [156] Reduced phosphodiesterase-2 activity in the amygdala results in anxiolytic-like effects on behavior in mice.J Psychopharmacol. 2019 May;33(5):568-576. doi: 10.1177/0269881119832753. Epub 2019 Mar 5.
• [157] SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV.J Antimicrob Chemother. 2019 Apr 1;74(4):1035-1043. doi: 10.1093/jac/dky508.
• [158] TRPM2 ion channel is involved in the aggravation of cognitive impairment and down regulation of epilepsy threshold in pentylenetetrazole-induced kindling mice.Brain Res Bull. 2020 Feb;155:48-60. doi: 10.1016/j.brainresbull.2019.11.018. Epub 2019 Nov 30.
• [159] Differential expression of VGLUT3 in laboratory mouse strains: Impact on drug-induced hyperlocomotion and anxiety-related behaviors.Genes Brain Behav. 2019 Mar;18(3):e12528. doi: 10.1111/gbb.12528. Epub 2018 Nov 6.
• [160] Correcting miR92a-vGAT-Mediated GABAergic Dysfunctions Rescues Human Tau-Induced Anxiety in Mice.Mol Ther. 2017 Jan 4;25(1):140-152. doi: 10.1016/j.ymthe.2016.10.010. Epub 2017 Jan 4.
• [161] VGluT1 Deficiency Impairs Visual Attention and Reduces the Dynamic Range of Short-Term Plasticity at Corticothalamic Synapses.Cereb Cortex. 2020 Mar 14;30(3):1813-1829. doi: 10.1093/cercor/bhz204.
• [162] Genetic alcohol sensitivity regulated by ALDH2 and ADH1B polymorphisms is strongly associated with depression and anxiety in Japanese employees.Drug Alcohol Depend. 2015 Feb 1;147:130-6. doi: 10.1016/j.drugalcdep.2014.11.034. Epub 2014 Dec 13.
• [163] Fibromyalgia, mood disorders, and intense creative energy: A1AT polymorphisms are not always silent.Neurotoxicology. 2012 Dec;33(6):1454-1472. doi: 10.1016/j.neuro.2012.03.001. Epub 2012 Mar 10.
• [164] FAAH-Catalyzed C-C Bond Cleavage of a New Multitarget Analgesic Drug.ACS Chem Neurosci. 2019 Jan 16;10(1):424-437. doi: 10.1021/acschemneuro.8b00315. Epub 2018 Oct 4.
• [165] An Extract of Artemisia dracunculus L. Promotes Psychological Resilience in a Mouse Model of Depression.Oxid Med Cell Longev. 2018 May 13;2018:7418681. doi: 10.1155/2018/7418681. eCollection 2018.
• [166] A risk PRODH haplotype affects sensorimotor gating, memory, schizotypy, and anxiety in healthy male subjects.Biol Psychiatry. 2009 Jun 15;65(12):1063-70. doi: 10.1016/j.biopsych.2009.01.003. Epub 2009 Feb 20.
• [167] The Relationship of UGT2B15 Pharmacogenetics and Lorazepam for Anxiety.Cureus. 2018 Aug 13;10(8):e3133. doi: 10.7759/cureus.3133.
• [168] Discovery and validation of blood biomarkers for suicidality.Mol Psychiatry. 2013 Dec;18(12):1249-64. doi: 10.1038/mp.2013.95. Epub 2013 Aug 20.
• [169] Impaired D2 receptor-dependent dopaminergic transmission in prefrontal cortex of awake mouse model of Parkinson's disease.Brain. 2019 Oct 1;142(10):3099-3115. doi: 10.1093/brain/awz243.
• [170] Precision medicine for suicidality: from universality to subtypes and personalization.Mol Psychiatry. 2017 Sep;22(9):1250-1273. doi: 10.1038/mp.2017.128. Epub 2017 Aug 15.
• [171] Assessment of Placental Cortisol Pathway Gene Expression in Term Pregnant Women with Anxiety.Neuropsychobiology. 2019;77(1):1-7. doi: 10.1159/000490428. Epub 2018 Aug 15.
• [172] Prospective Study of Psychological Morbidity and Illness Perceptions in Young People With Inflammatory Bowel Disease.J Crohns Colitis. 2019 Aug 14;13(8):1003-1011. doi: 10.1093/ecco-jcc/jjz028.
• [173] Longitudinal Magnetic Resonance Imaging Analysis and Histological Characterization after Spinal Cord Injury in Two Mouse Strains with Different Functional Recovery: Gliosis as a Key Factor.J Neurotrauma. 2018 Dec 15;35(24):2924-2940. doi: 10.1089/neu.2017.5613. Epub 2018 Aug 10.
• [174] MAOA interacts with the ALDH2 gene in anxiety-depression alcohol dependence.Alcohol Clin Exp Res. 2010 Jul;34(7):1212-8. doi: 10.1111/j.1530-0277.2010.01198.x. Epub 2010 May 7.
• [175] What Comes First Metacognition or Negative Emotion? A Test of Temporal Precedence.Front Psychol. 2019 Nov 19;10:2507. doi: 10.3389/fpsyg.2019.02507. eCollection 2019.
• [176] The association of dopamine pathway gene score, nicotine dependence and smoking cessation in a rural male population of Shandong, China.Am J Addict. 2016 Sep;25(6):493-8. doi: 10.1111/ajad.12421. Epub 2016 Aug 4.
• [177] Activity-regulated cytoskeleton-associated protein (Arc/Arg3.1) regulates anxiety- and novelty-related behaviors.Genes Brain Behav. 2019 Sep;18(7):e12561. doi: 10.1111/gbb.12561. Epub 2019 Apr 15.
• [178] A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation.Hum Mutat. 2009 Jan;30(1):61-8. doi: 10.1002/humu.20814.
• [179] Blockade of TrkB receptors in the nucleus accumbens prior to heterotypic stress alters corticotropin-releasing hormone (CRH), vesicular glutamate transporter 2 (vGluT2) and glucocorticoid receptor (GR) within the mesolimbic pathway.Horm Behav. 2017 Apr;90:98-112. doi: 10.1016/j.yhbeh.2017.02.012. Epub 2017 Mar 15.
• [180] Cbln2 and Cbln4 are expressed in distinct medial habenula-interpeduncular projections and contribute to different behavioral outputs.Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10235-E10244. doi: 10.1073/pnas.1811086115. Epub 2018 Oct 4.
• [181] Developmental effects of serotonin 1A autoreceptors on anxiety and social behavior.Neuropsychopharmacology. 2014 Jan;39(2):291-302. doi: 10.1038/npp.2013.185. Epub 2013 Aug 2.
• [182] Anxiety Disorders Interview Schedule-Autism Addendum: Reliability and Validity in Children With Autism Spectrum Disorder.J Clin Child Adolesc Psychol. 2017 Jan-Feb;46(1):88-100. doi: 10.1080/15374416.2016.1233501. Epub 2016 Dec 7.
• [183] Coping and Anxiety in Caregivers of Dependent Older Adult Relatives.Int J Environ Res Public Health. 2019 May 12;16(9):1651. doi: 10.3390/ijerph16091651.
• [184] A Clinically Relevant Closed-Head Model of Single and Repeat Concussive Injury in the Adult Rat Using a Controlled Cortical Impact Device.J Neurotrauma. 2017 Apr 1;34(7):1351-1363. doi: 10.1089/neu.2016.4517. Epub 2016 Dec 2.
• [185] The evaluation of a continuing professional development package for primary care dentists designed to reduce stress, build resilience and improve clinical decision-making.Br Dent J. 2017 Aug 25;223(4):261-271. doi: 10.1038/sj.bdj.2017.712.
• [186] Anxiolytic effect of CPEB1 knockdown on the amygdala of a mouse model of inflammatory pain.Brain Res Bull. 2018 Mar;137:156-165. doi: 10.1016/j.brainresbull.2017.12.002. Epub 2017 Dec 11.
• [187] Risperidone and NAP protect cognition and normalize gene expression in a schizophrenia mouse model.Sci Rep. 2015 Nov 10;5:16300. doi: 10.1038/srep16300.
• [188] Are there depression and anxiety genetic markers and mutations? A systematic review.J Affect Disord. 2014 Oct;168:387-98. doi: 10.1016/j.jad.2014.07.016. Epub 2014 Jul 22.
• [189] Cafeteria-diet effects on cognitive functions, anxiety, fear response and neurogenesis in the juvenile rat.Neurobiol Learn Mem. 2018 Nov;155:197-207. doi: 10.1016/j.nlm.2018.07.014. Epub 2018 Jul 31.
• [190] Behavioral flexibility in a mouse model for obsessive-compulsive disorder: Impaired Pavlovian reversal learning in SAPAP3 mutants.Genes Brain Behav. 2019 Apr;18(4):e12557. doi: 10.1111/gbb.12557. Epub 2019 Feb 27.
• [191] Deletion of Dlk2 increases the vulnerability to anxiety-like behaviors and impairs the anxiolytic action of alprazolam.Psychoneuroendocrinology. 2017 Nov;85:134-141. doi: 10.1016/j.psyneuen.2017.08.015. Epub 2017 Aug 31.
• [192] First genome-wide association study on anxiety-related behaviours in childhood.PLoS One. 2013;8(4):e58676. doi: 10.1371/journal.pone.0058676. Epub 2013 Apr 2.
• [193] Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease.Parkinsonism Relat Disord. 2017 Aug;41:113-117. doi: 10.1016/j.parkreldis.2017.05.003. Epub 2017 May 8.
• [194] P11 Loss-of-Function is Associated with Decreased Cell Proliferation and Neurobehavioral Disorders in Mice.Int J Biol Sci. 2019 May 20;15(7):1383-1395. doi: 10.7150/ijbs.33773. eCollection 2019.
• [195] Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial.J Child Adolesc Psychopharmacol. 2017 Feb;27(1):29-37. doi: 10.1089/cap.2016.0132. Epub 2017 Feb 6.
• [196] A new F-box protein 7 gene mutation causing typical Parkinson's disease.Mov Disord. 2015 Jul;30(8):1130-3. doi: 10.1002/mds.26266. Epub 2015 May 23.
• [197] Inactivation of fibroblast growth factor binding protein 3 causes anxiety-related behaviors.Mol Cell Neurosci. 2011 Jan;46(1):200-12. doi: 10.1016/j.mcn.2010.09.003. Epub 2010 Sep 21.
• [198] Foxg1 deletion impairs the development of the epithalamus.Mol Brain. 2018 Feb 2;11(1):5. doi: 10.1186/s13041-018-0350-2.
• [199] GPR26-deficient mice display increased anxiety- and depression-like behaviors accompanied by reduced phosphorylated cyclic AMP responsive element-binding protein level in central amygdala.Neuroscience. 2011 Nov 24;196:203-14. doi: 10.1016/j.neuroscience.2011.08.069. Epub 2011 Sep 8.
• [200] Maternal Alexithymia and Attachment Style: Which Relationship with Their Children's Headache Features and Psychological Profile?.Front Neurol. 2018 Jan 22;8:751. doi: 10.3389/fneur.2017.00751. eCollection 2017.
• [201] Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia.Genes Brain Behav. 2005 Jul;4(5):273-88. doi: 10.1111/j.1601-183X.2005.00120.x.
• [202] Contribution of health motive to cannabis use among high-school students.Addict Behav. 2017 Jan;64:54-56. doi: 10.1016/j.addbeh.2016.08.011. Epub 2016 Aug 10.
• [203] IgSF9b regulates anxiety behaviors through effects on centromedial amygdala inhibitory synapses.Nat Commun. 2018 Dec 20;9(1):5400. doi: 10.1038/s41467-018-07762-1.
• [204] Biopsychosocial influence on exercise-induced injury: genetic and psychological combinations are predictive of shoulder pain phenotypes.J Pain. 2014 Jan;15(1):68-80. doi: 10.1016/j.jpain.2013.09.012. Epub 2013 Oct 5.
• [205] Importin 5 Regulates Anxiety through MeCP2 and Sphingosine Kinase 1.Cell Rep. 2018 Dec 11;25(11):3169-3179.e7. doi: 10.1016/j.celrep.2018.11.066.
• [206] The involvement of the vasopressin system in stress-related disorders.CNS Neurol Disord Drug Targets. 2006 Apr;5(2):167-79. doi: 10.2174/187152706776359664.
• [207] Loss of Maged1 results in obesity, deficits of social interactions, impaired sexual behavior and severe alteration of mature oxytocin production in the hypothalamus.Hum Mol Genet. 2012 Nov 1;21(21):4703-17. doi: 10.1093/hmg/dds310. Epub 2012 Aug 2.
• [208] Association of anxiety with subcortical amyloidosis in cognitively normal older adults.Mol Psychiatry. 2020 Oct;25(10):2599-2607. doi: 10.1038/s41380-018-0214-2. Epub 2018 Aug 16.
• [209] Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease.Cell Mol Life Sci. 2012 Nov;69(21):3683-700. doi: 10.1007/s00018-012-1047-9. Epub 2012 Jun 22.
• [210] Mitochondrial Gene Expression Profiles Are Associated with Maternal Psychosocial Stress in Pregnancy and Infant Temperament.PLoS One. 2015 Sep 29;10(9):e0138929. doi: 10.1371/journal.pone.0138929. eCollection 2015.
• [211] High resolution magnetic resonance imaging for characterization of the neuroligin-3 knock-in mouse model associated with autism spectrum disorder.PLoS One. 2014 Oct 9;9(10):e109872. doi: 10.1371/journal.pone.0109872. eCollection 2014.
• [212] NPAS2 Regulation of Anxiety-Like Behavior and GABAA Receptors.Front Mol Neurosci. 2017 Nov 3;10:360. doi: 10.3389/fnmol.2017.00360. eCollection 2017.
• [213] Alterations in anxiety and social behaviour in Npas4 deficient mice following photochemically-induced focal cortical stroke.Behav Brain Res. 2017 Jan 1;316:29-37. doi: 10.1016/j.bbr.2016.08.050. Epub 2016 Aug 26.
• [214] Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial.J Gen Intern Med. 2019 Jun;34(6):862-870. doi: 10.1007/s11606-019-04858-2. Epub 2019 Mar 7.
• [215] Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception.J Biol Chem. 2001 Oct 5;276(40):36961-9. doi: 10.1074/jbc.M105308200. Epub 2001 Jul 31.
• [216] Hippocampal expression of a virus-derived protein impairs memory in mice.Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):1611-1616. doi: 10.1073/pnas.1711977115. Epub 2018 Jan 29.
• [217] Examining the relationships between error-related brain activity (the ERN) and anxiety disorders versus externalizing disorders in young children: Focusing on cognitive control, fear, and shyness.Compr Psychiatry. 2018 Nov;87:112-119. doi: 10.1016/j.comppsych.2018.09.009. Epub 2018 Oct 7.
• [218] The pain course: a randomised controlled trial comparing a remote-delivered chronic pain management program when provided in online and workbook formats.Pain. 2017 Jul;158(7):1289-1301. doi: 10.1097/j.pain.0000000000000916.
• [219] Is therapist evaluation of Social Anxiety/Avoidance traits associated with patient-reported attachment style?.Psychiatry Res. 2017 Nov;257:526-532. doi: 10.1016/j.psychres.2017.08.005. Epub 2017 Aug 10.
• [220] Mid-childhood outcomes of infant siblings at familial high-risk of autism spectrum disorder.Autism Res. 2017 Mar;10(3):546-557. doi: 10.1002/aur.1733. Epub 2016 Nov 29.
• [221] Interaction of the neuropeptide S receptor gene AsnIle variant and environment: contribution to affective and anxiety disorders, and suicidal behaviour.Int J Neuropsychopharmacol. 2014 Apr;17(4):541-52. doi: 10.1017/S1461145713001478. Epub 2013 Dec 16.
• [222] Age-dependent differential regulation of anxiety- and depression-related behaviors by neurabin and spinophilin.PLoS One. 2017 Jul 10;12(7):e0180638. doi: 10.1371/journal.pone.0180638. eCollection 2017.
• [223] PRND 3'UTR polymorphism may be associated with behavioral disturbances in Alzheimer disease.Prion. 2012 Jan-Mar;6(1):73-80. doi: 10.4161/pri.6.1.18428.
• [224] Genetic polymorphisms in the PACAP and PAC1 receptor genes and treatment response to venlafaxine XR in generalized anxiety disorder.Psychiatry Res. 2013 Dec 30;210(3):1299-300. doi: 10.1016/j.psychres.2013.07.038. Epub 2013 Aug 22.
• [225] G7-specific prothymosin alpha deletion causes stress- and age-dependent motor dysfunction and anxiety.Biochem Biophys Res Commun. 2020 Jan 29;522(1):264-269. doi: 10.1016/j.bbrc.2019.11.103. Epub 2019 Nov 20.
• [226] Brain specific Lamellipodin knockout results in hyperactivity and increased anxiety of mice.Sci Rep. 2017 Jul 14;7(1):5365. doi: 10.1038/s41598-017-05043-3.
• [227] An EJC factor RBM8a regulates anxiety behaviors.Curr Mol Med. 2013 Jul;13(6):887-99. doi: 10.2174/15665240113139990019.
• [228] Regulator of calcineurin 1 modulates expression of innate anxiety and anxiogenic responses to selective serotonin reuptake inhibitor treatment.J Neurosci. 2013 Oct 23;33(43):16930-44. doi: 10.1523/JNEUROSCI.3513-12.2013.
• [229] Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy.Am Heart J. 2017 Jul;189:75-84. doi: 10.1016/j.ahj.2017.03.009. Epub 2017 Mar 20.
• [230] Evaluation of the PAI-A Anxiety and Depression Scales: Evidence of Construct Validity.J Pers Assess. 2018 May-Jun;100(3):313-320. doi: 10.1080/00223891.2017.1347569. Epub 2017 Jul 31.
• [231] The emerging role of SHANK genes in neuropsychiatric disorders.Dev Neurobiol. 2014 Feb;74(2):113-22. doi: 10.1002/dneu.22128. Epub 2013 Oct 7.
• [232] Overexpression of Spexin 1 in the Dorsal Habenula Reduces Anxiety in Zebrafish.Front Neural Circuits. 2019 Aug 14;13:53. doi: 10.3389/fncir.2019.00053. eCollection 2019.
• [233] Substance P: A neuropeptide involved in the psychopathology of anxiety disorders.Neuropeptides. 2020 Feb;79:101993. doi: 10.1016/j.npep.2019.101993. Epub 2019 Nov 11.
• [234] Altered TAOK2 activity causes autism-related neurodevelopmental and cognitive abnormalities through RhoA signaling.Mol Psychiatry. 2019 Sep;24(9):1329-1350. doi: 10.1038/s41380-018-0025-5. Epub 2018 Feb 21.
• [235] The effect of intracerebroventricular administration of orexin receptor type 2 antagonist on pentylenetetrazol-induced kindled seizures and anxiety in rats.BMC Neurosci. 2018 Aug 13;19(1):49. doi: 10.1186/s12868-018-0445-9.
• [236] Teneurin proteins possess a carboxy terminal sequence with neuromodulatory activity.Brain Res Mol Brain Res. 2005 Feb 18;133(2):253-65. doi: 10.1016/j.molbrainres.2004.10.019.
• [237] Single-nucleotide polymorphism in the human TIA1 gene interacts with stressful life events to predict the development of pathological anxiety symptoms in a Swedish population.J Affect Disord. 2020 Jan 1;260:597-603. doi: 10.1016/j.jad.2019.09.018. Epub 2019 Sep 3.
• [238] Anxiety Associated Increased CpG Methylation in the Promoter of Asb1: A Translational Approach Evidenced by Epidemiological and Clinical Studies and a Murine Model.Neuropsychopharmacology. 2018 Jan;43(2):342-353. doi: 10.1038/npp.2017.102. Epub 2017 May 25.
• [239] Psychological factors predict an unfavorable pain trajectory after hysterectomy: a prospective cohort study on chronic postsurgical pain.Pain. 2018 May;159(5):956-967. doi: 10.1097/j.pain.0000000000001170.
• [240] Homer2 within the central nucleus of the amygdala modulates withdrawal-induced anxiety in a mouse model of binge-drinking.Neuropharmacology. 2018 Jan;128:448-459. doi: 10.1016/j.neuropharm.2017.11.001. Epub 2017 Nov 3.
• [241] Patients with overlapping diagnoses of asthma and COPD: is livestock exposure a risk factor for comorbidity and coexisting symptoms and infections?.BMC Pulm Med. 2019 Jun 10;19(1):105. doi: 10.1186/s12890-019-0865-z.
• [242] Rikkunshito simultaneously improves dyspepsia correlated with anxiety in patients with functional dyspepsia: A randomized clinical trial (the DREAM study).Neurogastroenterol Motil. 2018 Jul;30(7):e13319. doi: 10.1111/nmo.13319. Epub 2018 Mar 2.
• [243] Loss of Lypd6 leads to reduced anxiety-like behaviour and enhanced responses to nicotine.Prog Neuropsychopharmacol Biol Psychiatry. 2018 Mar 2;82:86-94. doi: 10.1016/j.pnpbp.2017.11.025. Epub 2017 Nov 28.
• [244] Effects of anxiety sensitivity reduction on smoking abstinence: An analysis from a panic prevention program.J Consult Clin Psychol. 2018 May;86(5):474-485. doi: 10.1037/ccp0000288.
• [245] Novel splicing mutation in the ASXL3 gene causing Bainbridge-Ropers syndrome.Am J Med Genet A. 2016 Jul;170(7):1863-7. doi: 10.1002/ajmg.a.37653. Epub 2016 Apr 13.
• [246] Ca(2+)-dependent activator protein for secretion 2 and autistic-like phenotypes.Neurosci Res. 2010 Jul;67(3):197-202. doi: 10.1016/j.neures.2010.03.006. Epub 2010 Mar 17.
• [247] Deletion of Dtnbp1 in mice impairs threat memory consolidation and is associated with enhanced inhibitory drive in the amygdala.Transl Psychiatry. 2019 Apr 9;9(1):132. doi: 10.1038/s41398-019-0465-y.
• [248] The chromatin-binding protein HMGN1 regulates the expression of methyl CpG-binding protein 2 (MECP2) and affects the behavior of mice.J Biol Chem. 2011 Dec 9;286(49):42051-42062. doi: 10.1074/jbc.M111.300541. Epub 2011 Oct 17.
• [249] Zfp462 deficiency causes anxiety-like behaviors with excessive self-grooming in mice.Genes Brain Behav. 2017 Feb;16(2):296-307. doi: 10.1111/gbb.12339. Epub 2016 Oct 7.
• [250] Relationships between coping, anxiety, depression and health-related quality of life in outpatients with substance use disorders: results of the SUBUSQOL study.Psychol Health Med. 2020 Feb;25(2):179-189. doi: 10.1080/13548506.2019.1679847. Epub 2019 Oct 17.
• [251] Viral-mediated overexpression of the Myelin Transcription Factor 1 (MyT1) in the dentate gyrus attenuates anxiety- and ethanol-related behaviors in rats.Psychopharmacology (Berl). 2017 Jun;234(12):1829-1840. doi: 10.1007/s00213-017-4588-7. Epub 2017 Mar 16.
• [252] Lack of association between SNPs in the NEUROD2 gene and alcohol dependence in a German patient sample.Psychiatry Res. 2011 May 15;187(1-2):220-3. doi: 10.1016/j.psychres.2010.08.031. Epub 2010 Sep 28.
• [253] Anxiety and somatic symptoms among elderly patients with depression.Asian J Psychiatr. 2019 Mar;41:66-72. doi: 10.1016/j.ajp.2018.07.009. Epub 2018 Jul 18.
• [254] Chronic harsh parenting and anxiety associations with fear circuitry function in healthy adolescents: A preliminary study.Biol Psychol. 2019 Jul;145:198-210. doi: 10.1016/j.biopsycho.2019.03.019. Epub 2019 Mar 29.
• [255] Effect of chronic unpredictable stress on mice with developmental under-expression of the Ahi1 gene: behavioral manifestations and neurobiological correlates.Transl Psychiatry. 2018 Jul 2;8(1):124. doi: 10.1038/s41398-018-0171-1.
• [256] Further evidence for genetic variation at the serotonin transporter gene SLC6A4 contributing toward anxiety.Psychiatr Genet. 2017 Jun;27(3):96-102. doi: 10.1097/YPG.0000000000000171.
• [257] Dynamic Pruritus Score: Evaluation of the Validity and Reliability of a New Instrument to Assess the Course of Pruritus.Acta Derm Venereol. 2017 Feb 8;97(2):230-234. doi: 10.2340/00015555-2494.
• [258] Psychological predictors of quality of life and functional outcome in patients undergoing elective surgery for degenerative lumbar spine disease.Eur Spine J. 2020 Feb;29(2):349-359. doi: 10.1007/s00586-019-06106-x. Epub 2019 Aug 14.
• [259] Assessment of oral health-related quality of life, measured by OHIP-14 and GOHAI, and psychological profiling in burning mouth syndrome: A case-control clinical study.J Oral Rehabil. 2020 Jan;47(1):42-52. doi: 10.1111/joor.12864. Epub 2019 Aug 10.
• [260] Problematic internet use and psychiatric co-morbidity in a population of Japanese adult psychiatric patients.BMC Psychiatry. 2018 Jan 17;18(1):9. doi: 10.1186/s12888-018-1588-z.
• [261] Family contributions to sport performance and their utility in predicting appropriate referrals to mental health optimization programmes.Eur J Sport Sci. 2019 Aug;19(7):972-982. doi: 10.1080/17461391.2019.1574906. Epub 2019 Feb 8.
• [262] Anxiety, Depression, and Pain Symptoms: Associations With the Course of Marijuana Use and Drug Use Consequences Among Urban Primary Care Patients.J Addict Med. 2018 Jan/Feb;12(1):45-52. doi: 10.1097/ADM.0000000000000362.
• [263] Who needs more than standard care? Treatment moderators in a randomized clinical trial comparing addiction treatment alone to addiction treatment plus anxiety disorder treatment for comorbid anxiety and substance use disorders.Behav Res Ther. 2018 Aug;107:1-9. doi: 10.1016/j.brat.2018.05.005. Epub 2018 May 17.
• [264] Expression of the PPM1F Gene Is Regulated by Stress and Associated With Anxiety and Depression.Biol Psychiatry. 2018 Feb 1;83(3):284-295. doi: 10.1016/j.biopsych.2017.08.013. Epub 2017 Aug 30.
• [265] Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species.Proc Natl Acad Sci U S A. 2019 May 28;116(22):10943-10951. doi: 10.1073/pnas.1901777116. Epub 2019 May 16.
• [266] Abrogated Freud-1/Cc2d1a Repression of 5-HT1A Autoreceptors Induces Fluoxetine-Resistant Anxiety/Depression-Like Behavior.J Neurosci. 2017 Dec 6;37(49):11967-11978. doi: 10.1523/JNEUROSCI.1668-17.2017. Epub 2017 Nov 3.
• [267] Benefit of continuous positive airway pressure on work quality in patients with severe obstructive sleep apnea.Sleep Breath. 2019 Sep;23(3):753-759. doi: 10.1007/s11325-018-01773-4. Epub 2019 Jan 26.
• [268] Opioid use before and after completion of an online pain management program.J Consult Clin Psychol. 2019 Oct;87(10):904-917. doi: 10.1037/ccp0000407.
• [269] Psychosocial and Cardiometabolic Health of Patients With Differing Body Mass Index Completing Cardiac Rehabilitation.Can J Cardiol. 2019 Jun;35(6):712-720. doi: 10.1016/j.cjca.2019.02.024. Epub 2019 Mar 6.
• [270] Melatonin ameliorates anxiety and depression-like behaviors and modulates proteomic changes in triple transgenic mice of Alzheimer's disease.Biofactors. 2017 Jul 8;43(4):593-611. doi: 10.1002/biof.1369. Epub 2017 Jun 13.
• [271] Poor sleep quality increases symptoms of depression and anxiety in postpartum women.J Behav Med. 2018 Oct;41(5):703-710. doi: 10.1007/s10865-018-9950-7. Epub 2018 Jul 20.
• [272] Determining Factors for Stress Perception Assessed with the Perceived Stress Scale (PSS-4) in Spanish and Other European Samples.Front Psychol. 2018 Jan 26;9:37. doi: 10.3389/fpsyg.2018.00037. eCollection 2018.
• [273] Evaluation of depression, anxiety and stress levels in patients with oral lichen planus.J Oral Sci. 2019 Aug 28;61(3):391-397. doi: 10.2334/josnusd.18-0113. Epub 2019 Jun 10.
• [274] Validity of the Brief Symptom Inventory-18 (BSI-18) for identifying depression and anxiety in young adult cancer survivors: Comparison with a Structured Clinical Diagnostic Interview.Psychol Assess. 2017 Oct;29(10):1189-1200. doi: 10.1037/pas0000427. Epub 2017 Jan 12.
• [275] Anxiogenic-like behavior and deficient attention/working memory in rats expressing the human DISC1 gene.Pharmacol Biochem Behav. 2019 Apr;179:73-79. doi: 10.1016/j.pbb.2019.02.005. Epub 2019 Feb 16.
• [276] Genetic variants of the BDNF and DRD3 genes in bipolar disorder comorbid with anxiety disorder.J Affect Disord. 2013 Dec;151(3):967-72. doi: 10.1016/j.jad.2013.08.017. Epub 2013 Aug 27.
• [277] 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety.Am J Drug Alcohol Abuse. 2019;45(2):161-169. doi: 10.1080/00952990.2018.1545024. Epub 2019 Mar 1.
• [278] Psychedelics and Dying Care: A Historical Look at the Relationship between Psychedelics and Palliative Care.J Psychoactive Drugs. 2019 Apr-Jun;51(2):102-107. doi: 10.1080/02791072.2019.1581308. Epub 2019 Mar 1.
• [279] Genome-wide association study of co-occurring anxiety in major depression.World J Biol Psychiatry. 2013 Dec;14(8):611-21. doi: 10.3109/15622975.2013.782107. Epub 2013 Sep 19.
• [280] Preoperative Carbohydrate Loading in Gynecological Patients Undergoing Combined Spinal and Epidural Anesthesia.J Invest Surg. 2020 Aug;33(7):587-595. doi: 10.1080/08941939.2018.1546352. Epub 2019 Jan 15.
• [281] Somatic effects of AAS abuse: A 30-years follow-up study of male former power sports athletes.J Sci Med Sport. 2017 Sep;20(9):814-818. doi: 10.1016/j.jsams.2017.03.008. Epub 2017 Mar 21.
• [282] Anxiety and depression in irritable bowel syndrome: Exploring the interaction with other symptoms and pathophysiology using multivariate analyses.Neurogastroenterol Motil. 2019 Aug;31(8):e13619. doi: 10.1111/nmo.13619. Epub 2019 May 5.
• [283] Mental Illnesses-Associated Fxr1 and Its Negative Regulator Gsk3 Are Modulators of Anxiety and Glutamatergic Neurotransmission.Front Mol Neurosci. 2018 Apr 12;11:119. doi: 10.3389/fnmol.2018.00119. eCollection 2018.
• [284] Brain galanin system genes interact with life stresses in depression-related phenotypes.Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):E1666-73. doi: 10.1073/pnas.1403649111. Epub 2014 Mar 24.
• [285] Variation in the Williams syndrome GTF2I gene and anxiety proneness interactively affect prefrontal cortical response to aversive stimuli.Transl Psychiatry. 2015 Aug 18;5(8):e622. doi: 10.1038/tp.2015.98.
• [286] Longitudinal Evaluation of the Cognitive-Behavioral Model of ADHD in a Sample of College Students With ADHD.J Atten Disord. 2018 Feb;22(4):323-333. doi: 10.1177/1087054715616184. Epub 2015 Dec 4.
• [287] Screening for posttraumatic stress disorder in ARDS survivors: validation of the Impact of Event Scale-6 (IES-6).Crit Care. 2019 Aug 7;23(1):276. doi: 10.1186/s13054-019-2553-z.
• [288] Cystic cerebellar dysplasia and biallelic LAMA1 mutations: a lamininopathy associated with tics, obsessive compulsive traits and myopia due to cell adhesion and migration defects.J Med Genet. 2016 May;53(5):318-29. doi: 10.1136/jmedgenet-2015-103416. Epub 2016 Jan 13.
• [289] An Internet-Based Compassion-Focused Intervention for Increased Self-Criticism: A Randomized Controlled Trial.Behav Ther. 2019 Mar;50(2):430-445. doi: 10.1016/j.beth.2018.08.003. Epub 2018 Aug 17.
• [290] An Exploratory Study on the Effects of Forest Therapy on Sleep Quality in Patients with Gastrointestinal Tract Cancers.Int J Environ Res Public Health. 2019 Jul 10;16(14):2449. doi: 10.3390/ijerph16142449.
• [291] Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities.Mol Psychiatry. 2014 Mar;19(3):368-79. doi: 10.1038/mp.2013.42. Epub 2013 Apr 16.
• [292] Role of multiple endocrine neoplasia type 1 mutational analysis in clinical practice.Endocr Pract. 2011 Jul-Aug;17 Suppl 3:8-17. doi: 10.4158/EP10379.RA.
• [293] Using Mobile Sensing to Test Clinical Models of Depression, Social Anxiety, State Affect, and Social Isolation Among College Students.J Med Internet Res. 2017 Mar 3;19(3):e62. doi: 10.2196/jmir.6820.
• [294] Cornelia de Lange syndrome: a case study.Genet Test Mol Biomarkers. 2009 Feb;13(1):15-8. doi: 10.1089/gtmb.2008.0057.
• [295] Neuroligin 2 nonsense variant associated with anxiety, autism, intellectual disability, hyperphagia, and obesity.Am J Med Genet A. 2017 Jan;173(1):213-216. doi: 10.1002/ajmg.a.37977. Epub 2016 Nov 16.
• [296] Behavioral phenotypes in males with XYY and possible role of increased NLGN4Y expression in autism features.Genes Brain Behav. 2015 Feb;14(2):137-44. doi: 10.1111/gbb.12200. Epub 2015 Feb 1.
• [297] Sustained overexpression of neuropeptide S in the amygdala reduces anxiety-like behavior in rats.Behav Brain Res. 2019 Jul 23;367:28-34. doi: 10.1016/j.bbr.2019.03.039. Epub 2019 Mar 23.
• [298] Neuroplastin 65 modulates anxiety- and depression-like behavior likely through adult hippocampal neurogenesis and central 5-HT activity.FEBS J. 2019 Sep;286(17):3401-3415. doi: 10.1111/febs.14865. Epub 2019 May 13.
• [299] Serotonin receptor 3A polymorphism c.-42C > T is associated with severe dyspepsia.BMC Med Genet. 2011 Oct 20;12:140. doi: 10.1186/1471-2350-12-140.
• [300] Disruption of the homeodomain transcription factor orthopedia homeobox (Otp) is associated with obesity and anxiety.Mol Metab. 2017 Nov;6(11):1419-1428. doi: 10.1016/j.molmet.2017.08.006. Epub 2017 Aug 24.
• [301] Pannexin-1 channel dysfunction in the medial prefrontal cortex mediates depressive-like behaviors induced by chronic social defeat stress and administration of mefloquine in mice.Neuropharmacology. 2018 Jul 15;137:256-267. doi: 10.1016/j.neuropharm.2017.12.004. Epub 2017 Dec 6.
• [302] Single prolonged stress PTSD model triggers progressive severity of anxiety, altered gene expression in locus coeruleus and hypothalamus and effected sensitivity to NPY.Eur Neuropsychopharmacol. 2019 Apr;29(4):482-492. doi: 10.1016/j.euroneuro.2019.02.010. Epub 2019 Mar 14.
• [303] Loss of offspring Peg3 reduces neonatal ultrasonic vocalizations and increases maternal anxiety in wild-type mothers.Hum Mol Genet. 2018 Feb 1;27(3):440-450. doi: 10.1093/hmg/ddx412.
• [304] A Measure of Suffering in relation to Anxiety and Quality of Life in IBS Patients: Preliminary Results.Biomed Res Int. 2017;2017:2387681. doi: 10.1155/2017/2387681. Epub 2017 Jul 4.
• [305] Modeling Strengthens Molecular Link between Circadian Polymorphisms and Major Mood Disorders.J Biol Rhythms. 2018 Jun;33(3):318-336. doi: 10.1177/0748730418764540. Epub 2018 Apr 3.
• [306] Lactobacillus paracasei PS23 reduced early-life stress abnormalities in maternal separation mouse model.Benef Microbes. 2019 Apr 19;10(4):425-436. doi: 10.3920/BM2018.0077. Epub 2019 Mar 18.
• [307] Interneuronal -GABA(A) receptors regulate binge drinking and are necessary for the behavioral effects of early withdrawal.Neuropsychopharmacology. 2019 Jan;44(2):425-434. doi: 10.1038/s41386-018-0164-z. Epub 2018 Jul 28.
• [308] REST/NRSF transcription factor is overexpressed in hippocampus of patients with drug-resistant mesial temporal lobe epilepsy.Epilepsy Behav. 2019 May;94:118-123. doi: 10.1016/j.yebeh.2019.02.012. Epub 2019 Mar 21.
• [309] Genetic association between RGS1 and internalizing disorders.Psychiatr Genet. 2013 Apr;23(2):56-60. doi: 10.1097/YPG.0b013e32835d7048.
• [310] SGCE mutations cause psychiatric disorders: clinical and genetic characterization.Brain. 2013 Jan;136(Pt 1):294-303. doi: 10.1093/brain/aws308.
• [311] Molecular and cellular basis of obsessive-compulsive disorder-like behaviors: emerging view from mouse models.Curr Opin Neurol. 2011 Apr;24(2):114-8. doi: 10.1097/WCO.0b013e32834451fb.
• [312] The role of phoenixin in behavior and food intake.Peptides. 2019 Apr;114:38-43. doi: 10.1016/j.peptides.2019.04.002. Epub 2019 Apr 3.
• [313] SRS-22r legacy scores can be accurately translated to PROMIS scores in adult spinal deformity patients.Spine J. 2020 Feb;20(2):234-240. doi: 10.1016/j.spinee.2019.09.006. Epub 2019 Sep 13.
• [314] Inflammatory markers as predictors of depression and anxiety in adolescents: Statistical model building with component-wise gradient boosting.J Affect Disord. 2018 Jul;234:276-281. doi: 10.1016/j.jad.2018.03.006. Epub 2018 Mar 12.
• [315] Polymorphism in Tmem132d regulates expression and anxiety-related behavior through binding of RNA polymerase II complex.Transl Psychiatry. 2018 Jan 10;8(1):1. doi: 10.1038/s41398-017-0025-2.
• [316] Widespread pain in axial spondyloarthritis: clinical importance and gender differences.Arthritis Res Ther. 2018 Jul 27;20(1):156. doi: 10.1186/s13075-018-1626-8.
• [317] Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohort.BMJ Open. 2019 Jan 17;9(1):e024719. doi: 10.1136/bmjopen-2018-024719.
• [318] Music therapy and Alzheimer's disease: Cognitive, psychological, and behavioural effects.Neurologia. 2017 Jun;32(5):300-308. doi: 10.1016/j.nrl.2015.12.003. Epub 2016 Feb 17.
• [319] The impact of silencing feed-forward parvalbumin-expressing inhibitory interneurons in the cortico-thalamocortical network on seizure generation and behaviour.Neurobiol Dis. 2019 Dec;132:104610. doi: 10.1016/j.nbd.2019.104610. Epub 2019 Sep 5.
• [320] Dendritic spine morphology and memory formation depend on postsynaptic Caskin proteins.Sci Rep. 2019 Nov 14;9(1):16843. doi: 10.1038/s41598-019-53317-9.
• [321] Long lasting behavioural effects on cuprizone fed mice after neurotoxicant withdrawal.Behav Brain Res. 2019 May 2;363:38-44. doi: 10.1016/j.bbr.2019.01.036. Epub 2019 Jan 28.
• [322] Altered default mode network connectivity in adolescents with post-traumatic stress disorder.Neuroimage Clin. 2019;22:101731. doi: 10.1016/j.nicl.2019.101731. Epub 2019 Feb 22.
• [323] The alpha- and beta-noradrenergic receptors blockade in the dorsal raphe nucleus impairs the panic-like response elaborated by medial hypothalamus neurons.Brain Res. 2019 Dec 15;1725:146468. doi: 10.1016/j.brainres.2019.146468. Epub 2019 Sep 18.
• [324] Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS).Methods Mol Biol. 2019;1942:173-189. doi: 10.1007/978-1-4939-9080-1_15.
• [325] Cognitive interference as a possible therapeutic strategy to prevent expression of benzodiazepine withdrawal.Eur J Neurosci. 2019 Dec;50(11):3843-3854. doi: 10.1111/ejn.14515. Epub 2019 Jul 29.
• [326] Hyperactive and anxiolytic-like behaviors result from loss of COUP-TFI/Nr2f1 in the mouse cortex.Genes Brain Behav. 2019 Sep;18(7):e12556. doi: 10.1111/gbb.12556. Epub 2019 Feb 10.
• [327] Null mutation in P4h-tm leads to decreased fear and anxiety and increased social behavior in mice.Neuropharmacology. 2019 Jul 15;153:63-72. doi: 10.1016/j.neuropharm.2019.04.023. Epub 2019 Apr 25.
• [328] Dcf1 Affects Memory and Anxiety by Regulating NMDA and AMPA Receptors.Neurochem Res. 2019 Nov;44(11):2499-2505. doi: 10.1007/s11064-019-02866-6. Epub 2019 Sep 17.